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PSYCHOMETRIC PROPERTIES OF OBSTRUCTIVE SLEEP APNEA SCREENING 
MEASURES IN PATIENTS REFERRED TO A SLEEP CLINIC 
Jennifer N. Miller, PhD, BSN, RN 
University of Nebraska Medical Center, 2016 
Background: Obstructive Sleep Apnea (OSA) contributes to all-cause and cardiac mortality. 
There are no current guidelines for OSA screening in outpatient settings. An American Academy 
of Sleep Medicine task force is focusing on improving detection and categorization of OSA 
symptoms and severity to promote screening, assessment, and diagnosis of the disorder. The 
purpose of this study was to identify the psychometric properties of three self-report OSA 
screening measures (Berlin, Epworth Sleepiness Scale (ESS), STOP Bang) and an objective 
portable sleep monitor (PSM) compared to apnea-hypopnea index (AHI) levels (≥5, ≥ 15, and ≥ 
30) from polysomnogram (PSG).  
Methods: A methodological design was used. Patients referred to a sleep specialist for an OSA 
consultation were recruited and enrolled at initial sleep evaluation. Participants completed the 
three OSA self-report screening measures and those participants who met inclusion criteria were 
sent home with a PSM for one night measurement. Automatic scoring was used. PSGs were 
ordered by the physician and AHI results were obtained from the medical record. 
Results: Participants (N=170) were enrolled (88 male, 82 female; age 54.5, SD 5.0 years). 
Almost all participants completed the self-report OSA screening measures, approximately half 
completed PSM measurement, and the majority completed laboratory PSG. The STOP Bang had 
the highest levels of sensitivity; the ESS had the lowest. The ESS had the highest specificity and 
reliability level. The PSM measure had the highest positive predictive value (PPV). The PSM 
measure had the strongest psychometric properties of the screening measures.  
Conclusions: The STOP Bang was the preferred self-report OSA screening measure because of 
high sensitivity levels. A positive STOP Bang warrants assessment for OSA. The ESS is the least 
desirable screening measure. If a patient qualifies, further screening with a PSM is indicated. 
 
  
PSM measurement consistently predicted the presence of OSA but at the expense of low 
sensitivity at AHI levels ≥ 30. PSM results can guide the referral process from primary or 
specialty clinicians to sleep specialists
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Chapter I: Background 
Obstructive sleep apnea (OSA) is a common, yet underdiagnosed, sleep-related breathing 
disorder that significantly contributes to all-cause (Kendzerska, Gershon, Hawker, Leung, & 
Tomlinson, 2014; Qaseem et al., 2014) and cardiac mortality (Kendzerska et al., 2014). The 
estimated prevalence rate of moderate to severe OSA in the United States is approximately 10% 
to 20%. The rate is thought to be influenced by the obesity epidemic and to have increased 
dramatically over the past two decades (Peppard et al., 2013).  
Essential features of OSA include a repetitive partial (hypopnea) and/or complete (apnea) 
obstruction of the upper airway, marked by upper pharyngeal collapse with continuing efforts to 
breathe. Events can last 10 seconds to a minute in duration, resulting in intermittent desaturations 
in oxyhemoglobin levels and sleep fragmentation. Respiratory-effort related arousals (RERAs) 
are sequences of breaths with increased pressure for at least 10 seconds preceding an arousal with 
more normal pressures. The results of apneas, hypopneas, and RERAs are intermittent hypoxia, 
activation of oxygen free radicals, and an oxidative stress response (Berry et al., 2014). Long-
term inflammatory processes result in changes in the vascular endothelium, leading to atheroma 
formation and vascular events (Almendros et al., 2011; Xie, Pan, Ren, Du, & Guo, 2013).  
A study by Torres et al. found that gender, age, body mass index, nocturnal heart rate, 
and night and day-time blood pressure can be predictive of OSA. Other studies report a 
relationship between OSA and tachyarrhythmias  (Holmqvist et al., 2015; Kohli, Balachandran, & 
Malhotra, 2011), reduced left ventricular stroke volume (Yumino et al., 2013), stroke (Lipford et 
al., 2015), cognitive impairment (Aaronson et al., 2015), and insulin resistance (Heffner, 
Rozenfeld, Kai, Stephens, & Brown, 2012).  
 Patients present to their health care providers with daytime sleepiness and/or known 
OSA risk factors, such as obesity and CVD, but are not screened for symptoms, assessed, or 
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referred to a sleep specialist for diagnosis and treatment for the disorder (Jennum, Ibsen, & 
Kjellberg, 2013).  
The American Academy of Sleep Medicine (AASM) released a call for volunteers to 
serve on an OSA Assessment Tools Task Force. Two main goals for the task force are to evaluate 
the current OSA screening measures and to recommend whether the AASM needs to develop 
additional measures that improve detection of the disorder (American Academy of Sleep 
Medicine, 2016).  
The self-report screening measures used commonly to detect OSA are the Berlin 
Questionnaire (Berlin) (Netzer, Stoohs, Netzer, Clark, & Strohl, 1999) and the Epworth 
Sleepiness Scale (ESS) (Johns, 1991). The STOP Bang questionnaire has been used to predict 
airways obstructive events in pre-operative patients in the acute care setting but more outpatient 
validation studies are needed (Chung et al., 2008a). The increased need for polysomnography 
(PSG) services encouraged the development of an objective screening measure, the portable sleep 
monitors (PSM). Level III PSM, with four channels, are used for OSA screening and diagnosis in 
patients who meet criteria. Reporting of the apnea hypopnea index (AHI) or respiratory distress 
index (RDI) after PSM is mandatory for OSA diagnosis (Department of Health and Human 
Services & Centers for Medicare & Medicaid Services, 2013). PSG remains the gold standard for 
generating AHI levels ≥ 15 to diagnose OSA.    
Theoretical Background 
 Kohli, Balachandran, and Malhotra (2011) developed a pathophysiologic model that 
visually depicted the long-term effects of OSA on the cardiovascular system, titled “Effects of 
Obstructive Sleep Apnea on the Cardiovascular System” (Figure 1). The construction of the 
model was supported by epidemiological research. In the model, OSA is shown to have three 
main effects: arousal, decreased partial pressure of oxygen (pO2) and increased partial pressure of 
carbon dioxide (pCO2), and decreased intrathoracic pressure.  
3 
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Arousals are important to OSA because the diagnosis of the disorder is based upon the 
number of apneas, hypopneas, RERAs, and/or respiratory distress index that are measured by 
PSG. The frequent arousals result in sympathetic nervous system activation that cascades into 
increased heart rate and blood pressure. The second main effect shown in the model is cyclic 
hypoxemia (decreased pO2) and hypercapnia (increased CO2). These two effects result in 
myocardial vasodilation and increased oxygen delivery as well as an increase in oxidative stress, 
inflammation, and endothelial dysfunction. Lastly, a decrease in intrathoracic pressure causes an 
increase in left ventricular wall tension and increased myocardial oxygen demand. The long-term 
effects of OSA, shown at the bottom of the model, are hypertension, atherosclerosis, myocardial 
ischemia, left ventricular hypertrophy and failure, cardiac arrhythmias, and cerebrovascular 
disease.  








The conceptual framework for this study (Figure 2) was adapted from Kohli’s (Kohli et 
al., 2011). The pathophysiological effects of OSA need to be prevented or reduced. Figure 2 
illustrates the need for screening, assessment, and diagnosis of OSA. It is important to determine 
which screening measurement(s) is/are the most reliable, valid and has the highest sensitivity and 
specificity levels compared to PSG. The second component of this framework illustrates the 
cardiovascular consequences of untreated OSA, which is not included in this study but will be in 
future research. OSA diagnosis begins with the screening and assessment process. The screening 
process is more efficient with the use of reliable and valid OSA screening measures. The OSA 
screening measures selected were the Berlin, ESS, STOP Bang and a PSM (ApneaLink Air). The 
screening measures were psychometrically compared with AHI levels from PSG. 





The cardiovascular consequences included in the framework include tachycardia and 
hypertension caused by systemic activation of the sympathetic nervous system. Because of the 
excess stress placed on the body’s vascular system, blood pressure and heart rate increase along 
with decreased myocardial oxygen delivery. The result is development of cardiovascular disease 
(Kohli et al., 2011). Including the cardiovascular consequences of untreated OSA in the 
framework provides emphasis of the benefits of early screening and treatment of the sleep 
disorder.  
The current practice pattern is inconsistent for screening and assessment of OSA. This 
framework informs the study by emphasizing the importance of identifying measures that are 
highly predictive of OSA. The knowledge gained from this study will determine which 
measurement(s) has the best predictability for identifying OSA in undiagnosed patients in a sleep 
clinic setting. 
Definitions of Major Concepts 
Obstructive sleep apnea  
Essential features of OSA include a repetitive partial (hypopnea) and/or complete (apnea) 
obstruction of the upper airway, marked by upper pharyngeal collapse with continuing efforts to 
breathe (Berry et al., 2014). These events can last 10 seconds or up to a minute in duration, and 
result in intermittent desaturations in oxyhemoglobin levels and sleep fragmentation. In obese 
individuals, obstructive events in rapid eye movement sleep have been associated with lower 
oxyhemoglobin desaturations (Peppard, Ward, & Morrell, 2009). 
An AASM task force listed symptoms of OSA as loud snoring between apneas, witnessed 
episodes of gasping for air, choking, and the presence of daytime sleepiness. The severity of OSA 
is categorized by an individual’s AHI, indicating how many times an hour the patient experiences 
obstructive events during PSG testing (Epstein et al., 2009). AHI levels range from mild (≥ 5 and 
< 15), to moderate (15 ≥ and < 30 ), to severe (≥ 30 ) (Berry et al., 2014; Epstein et al., 2009; 
Guilleminault, Benbir, & Aktar, 2007). Daytime excessive sleepiness, fatigue and feeling 
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unrefreshed after sleep are common in most individuals with OSA and symptoms are exacerbated 
by more frequent apnic and hypopenic events (Epstein et al., 2009), these can be detected using 
sensitive and specific screening methods. 
Screening 
The definition for screening is “the act of doing a test on a person… to look for evidence 
of a disease” (Merriam-Webster Dictionary, 2014b). OSA screening currently takes place via the 
review of systems process but providers often do not include questions to detect sleep 
disturbances (Grover et al., 2011; Senthilvel, Auckley, & Dasarathy, 2011). Screening needs to 
occur during a routine health maintenance assessment or as part of a comprehensive exam for 
high-risk patients (Epstein et al., 2009). Physiologic characteristics that place a person at high-
risk of OSA are obesity (body mass index > 35), congestive heart failure, atrial fibrillation, 
hypertension, type II diabetes, stroke, pulmonary hypertension, and nocturnal cardiac arrhythmias 
(Epstein et al., 2009; Miller & Berger, 2016).  
An OSA screening measure can be used to predict OSA and to determine whether an 
assessment is warranted. The AASM Clinical Guidelines Task Force (Epstein et al., 2009) 
reached “consensus” that several questions can be asked by the primary care provider (PCP) 
during routine health maintenance assessments. Asking about a history of snoring and daytime 
sleepiness lacks reliability and validity and has not resulted in increased referrals to sleep 
specialists. PCPs need to use sensitive and specific measures to identify, high-risk patients for 
referral to a sleep specialist.  
Measurement 
OSA screening measures have been developed to aid health care providers to screening 
quickly for moderate to severe OSA in a variety of health care settings (Abrishami, Khajehdehi, 
& Chung, 2010; Ramachandran & Josephs, 2009; Silva, Vana, Goodwin, Sherrill, & Quan, 
2011). Using sensitive and specific screening measures offers a cost-effective way to predict the 
presence of OSA and highlights the need to refer the patient to a sleep specialist. Measures with 
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high positive predictive value are likely to predict the presence of a disease while those with high 
negative predicative values are likely to predict the absence of the disease. This section will 
discuss reliability and validity as well as provide a description of the OSA screening measures.  
Reliability. Reliability testing helps determine whether the health outcomes under study 
can provide reproducible results in the population. The reliability of a measurement is concerned 
with controlling random error, which can be caused by inconsistent responses to questionnaires, 
data entry errors, poor training of data collectors, or coding/transcription errors (Furr & 
Bacharach, 2014).  
Validity. DeVon et al. (2007) defined validity as “the ability of the instrument to measure 
the attributes of the construct under study” (p.155). Validity can be divided into three categories of 
measurement: (a) content, (b) criterion, and (c) construct validity (Kane & Radosevich, 2010). 
Content, or face validity refers to the comprehensiveness of the measurement that is established via 
content analysis. Criterion validity measures a correlation between an instrument and the gold 
standard of measurement. This category of validity can be subdivided into concurrent and 
predictive validity. Concurrent validity occurs when scores on a measure are correlated to related 
criterion at the same point in time. Predictive validity is the degree to which test scores predict 
performance on some future criterion, measured by sensitivity, specificity, positive predictive 
value, and negative predictive value. Sensitivity is the probability of a positive test among patients 
with a disease and specificity is the probability of a negative test among patients without a disease. 
Positive predictive value is the probability that subjects with a positive screen will truly have the 
disease and negative predictive value is the probability that subjects with a negative screen truly 
don’t have the disease (Kane & Radosevich, 2010).  
Construct validity uses scientific theory to support or refute a construct. Hypotheses can 
test operational definitions to determine whether the overarching theory supports the instrument 
being tested. Construct validity can be assessed by convergent/discriminant validity or known 
groups testing. Convergent validity compares two scales purporting to measure the same construct 
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that should be highly correlated/theoretically similar. Known groups testing uses a highly 
sensitive/specific measure (i.e. PSG) to determine differences in groups (DeVon et al., 2007; Kane 
& Radosevich, 2010).  
Berlin questionnaire. The Berlin questionnaire (Netzer et al., 1999) was developed by 
primary care and pulmonary physicians to predict the presence of OSA. The measurement has 
three symptom categories; the first has five unique questions concerning frequency (rare to often) 
of snoring and apneas while sleeping. The second category has four unique questions concerning 
daytime sleepiness with a question about sleepiness while driving. A score is positive for 
category 1 and 2 when a patient selects two responses from the top levels. The third category has 
two questions. A positive response is when a patient has high blood pressure (> 140/90mmHg) or 
a body mass index (BMI) > 30kg/m2. After scoring, the individual is considered to be high-risk if 
two or three of the categories are positive.  
Epworth sleepiness scale. The ESS (Johns, 1991) was developed as a simple measure to 
quantify the level of daytime sleepiness in adults. The ESS is a brief scale that asks the subject to 
rate on a scale of 0-3 (0=none, 3=high chance of dozing) the level of sleepiness during eight daily 
activities. The sum of the eight questions is calculated and the higher the sum, the higher the 
sleep deficit (0-24). A score of ≥16 indicates a high level of daytime sleepiness (Johns, 1991). 
The ESS has been shown to be reliable in the test-retest sense. The measure has high internal 
consistency (Johns, 1992) but inconsistent sensitivity and specificity values (El-Sayed, 2012; 
Silva et al., 2011).  
 STOP Bang. The STOP Bang is an OSA screening measure that was developed to 
quickly and concisely screen for OSA in a pre-surgical population. The eight OSA predictor 
variables are snoring, tiredness, obstruction, high blood pressure, BMI, age, neck circumference, 
and gender. Scoring takes place on a Yes/No scale (Chung et al., 2008a). The person is given one 
point for each “yes” response. Scores range from 0 to 8, with ≥3 indicating a positive screen.  
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ApneaLink Air. The ApneaLink AirTM (ResMed, San Diego, CA) is a level III, four 
channel, PSM that is prescribed by a health care provider. The device monitors (a) oxygen 
saturation, (b) heart rate, and (c) breathing patterns (apneas, hypopneas, snoring, probability of 
Cheyne-Stokes breathing). No known figures of test-retest reliability have been reported. An AHI 
level of ≥ 15 on the ApneaLink Air was the indicator of a positive screen (Collop et al., 2007). 
  Assessment 
A more comprehensive sleep history is recommended when an OSA screen is positive or 
the physician determines that assessment is warranted (Epstein et al., 2009). Assessment is 
defined as “the act of making a judgment about something” (Merriam-Webster Dictionary, 
2014a). No clinical measurement or assessment is absolutely predictive of the presence of OSA, 
but patients assessed as high-risk for the disorder should be referred to a sleep specialist for 
evaluation (Epstein et al., 2009).  
Assessments included are BMI, neck circumference, blood pressure, and a visual 
examination of the oro-naso-pharynx. Determining a Mallampati score is helpful in assessing 
posterior pharyngeal crowding caused by increased upper airway soft tissue or abnormal facial 
structures. Higher scores have been correlated with OSA severity (r= 0.351, p= 0.008) and may 
predict nighttime obstructive events. A class 1 Mallampati score is visualization of the entire soft 
palate; severity ranges to a class 4, which is the inability to see any part of the soft palate (Epstein 
et al., 2009).  
The assessment for OSA should include an examination of the cardiovascular and 
respiratory systems (Epstein et al., 2009). Untreated OSA is more likely to be present in persons 
with hypertension (Walia et al., 2014), or other cardiovascular conditions such as stroke (C. Chen 
et al., 2015) and Type II diabetes (Wang, Bi, Zhang, & Pan, 2013). Untreated OSA in the 
presence of dilated cardiomyopathy or ischemic heart disease can lead to the development of 
congestive heart failure (D. J. Gottlieb et al., 2010). Patients with severe untreated OSA, who also 
have chronic obstructive pulmonary disease, are at higher risk of developing pulmonary 
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hypertension and cor pulmonale. When screening and assessment indicate that a patient found is 
at high-risk for OSA, the referral process must be expedited for timely diagnosis and treatment 
(Epstein et al., 2009). 
Diagnosis 
Polysomnography. Under supervision of a sleep technician, laboratory PSG is the gold 
standard for OSA diagnosis. An AASM task force (2012) defined apnea events in adults as “a 
drop in the peak signal excursion by ≥ 90% of pre-event baseline using an oro nasal thermal 
sensor (diagnostic study), positive assisted pressure (PAP) device flow (titration study), or an 
alternative apnea sensor, for ≥ 10 seconds”(p. 606). Hypopnea events in adults are scored when 
“the peak signal excursions drop by ≥ 30% of pre-event baseline using nasal pressure (diagnostic 
study), PAP device flow (titration study), or an alternative sensor for ≥ 10 seconds in association 
with either ≥ 3% arterial oxygen desaturation or an arousal (Berry et al., 2012). The severity of 
OSA has been defined by AASM as “an individual’s Apnea Hypopnea Index (AHI), which 
indicates how many times an hour the patient experiences obstructive events” (Epstein et al., 
2009). AHI levels range from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30), to severe (≥ 30) 
(Berry et al., 2014; Epstein et al., 2009; Guilleminault et al., 2007).  
 Introduction of Documents 
This dissertation adds to the current knowledge of OSA screening, assessment, and 
diagnosis. The dissertation uses the three-manuscript option to present the current state of the 
science on this topic. Chapter II is an integrative literature review titled State of the Science: 
Screening and Assessment for Obstructive Sleep Apnea in Primary Care. Next, Chapter III is a 
focused literature review titled Methodological Challenges: Using Portable Sleep Monitoring in 
Research. Chapter IV.A. is the presentation of Aim 1 of the dissertation study as well as a 
discussion of its theoretical and conceptual framework titled Psychometric Properties of 
Obstructive Sleep Apnea Screening Measures in Patients Referred to a Sleep Clinic. Chapter 
IV.B. is the presentation of Aim 2 of the dissertation study, which is a multiple regression 
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analysis of demographic and clinical variables using AHI from laboratory PSG as the outcome 
variable titled Analysis of Demographic, Clinical, and Biomarker Characteristics to Determine 
Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern Sleep Clinic 
Patients. Chapter V presents conclusions and discussion of the research and implications for 
research and practice.   
Chapter II: State of the Science: Screening and Assessment for Obstructive Sleep Apnea in 
Primary Care 
 OSA is the most common sleep-related breathing disorder and contributes to increased 
morbidity and compromised cardiovascular outcomes. Sleep disorders are common but rarely 
reported and addressed by primary health providers. An American Academy of Sleep Medicine 
task force (2015) released quality measures for the care of adult patients with OSA; the first 
outcome is improved detection and categorization of OSA symptoms and severity to promote 
assessment and diagnosis of the disorder.  
This state of the science integrative review aimed to evaluate the screening and 
assessment for OSA in primary care settings including the psychometric properties of OSA 
screening measures. This paper is the first to focus on this issue. Studies that met inclusion 
criteria were fourteen non-experimental and three experimental designs. OSA screening measures 
(Berlin Questionnaire, Epworth Sleepiness Scale, STOP Bang) with extensive validation studies 
were examined. A critical evaluation of the current state of the science is provided as well as 
recommendations for future interdisciplinary research. 
Chapter III: Methodological Challenges in Using Portable Sleep Monitoring in Research 
 OSA in adults has been increasing over the last two decades. Currently, it is estimated 
that moderate to severe OSA (apnea hypopnea index [AHI] ≥ 15) is present in 10% of men aged 
30-49, 17% of men 50-70 years old, and 9% of women 50-70 years old. PSM type of testing is 
not recommended for patients with co-morbid conditions such as moderate to severe pulmonary 
disease, neuromuscular disease, congestive heart failure, or who are suspected to have other sleep 
12 
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disorders (central sleep apnea, periodic limb movement disorder, insomnia, parasomnias, 
circadian rhythm disorders, or narcolepsy) (Collop et al., 2007). Because of the increase in OSA 
prevalence, sleep laboratory and diagnostic services are in high demand; therefore, it was 
necessary to identify alternative means for screening and diagnosis of sleep disorder outside of 
the sleep laboratory.  
The first practice parameters were released for PSM in 1994 (Ferber et al., 1994). By the 
mid 1990’s, most devices measured snoring but did not meet diagnostic requirements for OSA. 
By the year 2000, PSM were updated to include oxygen saturation, heart rate, oral/nasal airflow, 
respiratory effort and body position (Cleveland Medical Devices Inc., 2016). In 2000, the Agency 
for Healthcare Research and Research Quality (AHRQ) performed a meta-analysis that stated 
broad use of PSM could not be supported due insufficient evidence (Ross et al., 2000). In 2007, 
the Portable Monitoring Task Force of the AASM released guidelines which stated patients could 
be screened and diagnosed with OSA in home settings with Level III PSMs (Collop et al., 2007). 
This encouraged device manufacturers to develop PSM that allow patients to be screened or 
diagnosed with OSA in home settings. PSM has increased in popularity in order to meet the 
challenges of decreased availability of sleep laboratory sources.  
 With the increased use of PSM in outpatient settings, it is important to understand the 
research that has been published on the topic using level III monitors and to be able to understand 
the methodological challenges that are common with the use of the devices in research. To 
provide a focused review on the methodological challenges when using portable sleep monitors in 
research, it was necessary to create two main objectives for this manuscript. The first purpose of 
this paper was to synthesize the literature of the methodological challenges in using level III PSM 
in research adult patents, in terms of: (a) participant sampling; (b) instrumentation issues; (c) 
clinical variables; (d) data processing options; and (e) patient acceptability. A second purpose was 
to identify methodological strategies to use to standardize PSM information in research reports. 
13 
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After implementing the exclusion criteria, 33 publications were included in the focused review 
and the strategies were identified from them.   
Chapter IV.A. Psychometric Properties of Obstructive Sleep Apnea Screening Measures in 
Patients Referred to a Sleep Clinic 
There are no current guidelines for screening for OSA in outpatient settings due to 
methodological issues with available measures. The screening measures that are often used to 
detect OSA are the Epworth Sleepiness Scale (ESS) (Johns, 1991) and the Berlin Questionnaire 
(Berlin) (Netzer et al., 1999). The STOP Bang questionnaire has been used to predict airways 
obstructive events in pre-operative patients in the acute care setting but more outpatient validation 
studies are needed (Chung et al., 2008a). A clinical practice guideline from the American College 
of Physicians, released in 2014, discussed the use of screening questionnaires for individuals with 
unexplained daytime sleepiness but states that they are not ready to be used as diagnostic tools for 
OSA (Qaseem et al., 2014). As previously discussed, PSM allows patients to be screened or 
diagnosed with OSA in home settings but limited studies discuss validation with screening 
measures and laboratory PSG. The knowledge gained from this study contributes to science by 
identifying the sensitivity and specificity of OSA measures used in screening.    
Therefore, in patients who have been referred to a sleep specialist for a sleep disordered 
breathing evaluation, the purpose of this methodological study was to identify the psychometric 
properties of OSA screening measures (Berlin, Epworth Sleepiness Scale, STOP Bang, 
ApneaLink Air) compared to AHI levels from PSG. Validation testing was completed with the 
screening measures and conclusions were drawn in terms of implications for research and 
practice.  
Chapter IV.B. Analysis of Demographic, Clinical, and Biomarker Characteristics to 
Determine Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern 
Sleep Clinic Patients 
14 
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OSA can occur in any age group but is most prevalent in older men (Kendzerska et al., 
2014) and post-menopausal women (Zhao et al., 2014). A recent population health study 
concluded that the incidence of OSA is increasing because of rising obesity rates (Adams et al., 
2012). OSA has been associated with hypertension (D. J. Gottlieb et al., 2014), congestive heart 
failure (D. J. Gottlieb et al., 2010), stroke (D. Gottlieb, Quan, Punjabi, Redline, & Bertisch, 
2014), vascular disease (Cassar et al., 2014), metabolic disorders (N. H. Kim et al., 2013), and 
coronary artery disease (Jennum et al., 2013; Young et al., 2008). Untreated OSA can exacerbate 
all of these comorbid conditions (Colten & Altevogt, 2006). 
Aim 2’s purpose was to examine if selected demographic (age, gender), clinical 
(diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, lung disease, 
smoking history, alcohol intake), and biomarker (blood pressure, heart rate, BMI, neck 
circumference, Mallampati Score) variables predict AHI levels from PSG. Significant predictor 
variables from the model were discussed in the conclusion as well as implications for future 
research and practice.  
Chapter V: Discussion and Conclusions of the Dissertation Research  
 This chapter provides additional insights into the understanding of the conclusions of 
these documents. Implications for research and practice are presented. Unique insights into 
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Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder and 
contributes to increased morbidity and compromised cardiovascular outcomes. Sleep disorders 
are common but rarely reported and addressed by primary health providers. An American 
Academy of Sleep Medicine task force (2015) released quality measures for the care of adult 
patients with OSA; the first outcome is improved detection and categorization of OSA symptoms 
and severity to promote assessment and diagnosis of the disorder.  
This state of the science integrative review aimed to evaluate the screening and 
assessment for OSA in primary care settings including the psychometric properties of OSA 
screening measures. Studies that met inclusion criteria were fourteen non-experimental and three 
experimental designs. OSA screening measurements (Berlin questionnaire, Epworth sleepiness 
scale, STOP Bang) with extensive validation studies were examined. Conclusions are that the 
current practice model of screening and assessment for OSA in primary care is fragmented and 
ineffective. Primary care providers encounter patients with OSA symptoms but do not routinely 
screen, assess, or refer to a sleep specialist. More psychometric research is needed for the OSA 
screening measurements in primary care. The results of these studies can be translated into 





Keywords: assessment; cardiovascular; evaluation; obstructive sleep apnea; measurement; 
screening; sleep related breathing disorders 
Abbreviations: AHI, apnea hypopnea index; BMI, body mass index; EMR, Electronic medical 
record; ESS, Epworth sleepiness scale; PAP, positive airway pressure; PCP, primary care 
provider; PSG, polysomnography; OSA, obstructive sleep apnea; US, United States 
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Chapter II: Screening and Assessment for Obstructive Sleep Apnea in Primary Care  
Introduction 
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder 
(National Heart, Lung, and Blood Institute, 2012) and contributes to increased morbidity and 
compromised cardiovascular outcomes (Campos-Rodriguez et al., 2012; Kendzerska et al., 2014; 
Qaseem et al., 2014). The pathologic cardiovascular changes associated with OSA result from 
multifactorial etiologies. Repetitive obstructive events during sleep are hypothesized to cause 
intermittent hypoxia, resulting in activation of oxygen free radicals and an oxidative stress 
response. A concurrent inflammatory process suggests that damage to the vascular endothelium 
leads to atheroma formation and vascular events (Almendros et al., 2011; Xie et al., 2013). 
Epidemiological studies have concluded that untreated severe OSA is a large public health burden 
in terms of cardiac morbidity and mortality (D. J. Gottlieb et al., 2013; Kendzerska et al., 2014). 
In 2015, an American Academy of Sleep Medicine (AASM) task force released quality measures 
for the care of adult patients with OSA. The first quality measure outcome is to improve detection 
and categorization of OSA symptoms and severity (Aurora et al., 2015).  
 Bailes and colleagues (2008; 2009) surveyed primary care and sleep clinic patients and 
found that sleep disorders are common but rarely addressed by primary care providers (PCP). A 
Canadian population-based study found that patients often do not report sleep disturbance 
consequences to their PCP because their symptoms are chronic and difficult to explain (Bartlett, 
Marshall, Williams, & Grunstein, 2008). Daytime functioning complaints or insomnia symptoms 
are not recognized as consequences of OSA (Bailes et al., 2009). Congruently, many PCPs do not 
routinely screen or assess for sleep disturbances (Burgess, Havryk, Newton, Tsai, & Whitelaw, 
2013; Grover et al., 2011). Patients present with known OSA risk factors, such as obesity and 
CVD, but are not screened for symptoms, assessed, or referred to a sleep specialist for diagnosis 
and treatment for the disorder (Jennum et al., 2013). Because PCPs and other clinicians fall short 
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in recognizing OSA, more education is needed to detect patients at high-risk for the sleep 
disorder.  
Background 
OSA can occur in any age group, but is most prevalent in older men (Kendzerska et al., 
2014) and post-menopausal women (Zhao et al., 2014). OSA may be poorly recognized in pre-
menopausal women because symptoms are often nonspecific, such as insomnia, headaches, or 
fatigue (Attarian & Viola-Saltzman, 2006). A recent population health study concluded that the 
incidence of OSA is increasing in men and women due to rising obesity rates and practitioners 
need to adopt a proactive approach to diagnosis (Adams et al., 2012). Cardiovascular disease is 
the leading cause of mortality in the United States (US) (J. I. Kim, Sillah, Boucher, Sidebottom, 
& Knickelbine, 2013). Both the National Institutes of Health (2013) and the American Heart 
Association (2013) have emphasized the need to improve cardiovascular health nationwide. OSA 
is associated with cardiovascular disease (Cassar et al., 2014; D. J. Gottlieb et al., 2014; D. J. 
Gottlieb et al., 2010; N. H. Kim et al., 2013; Young et al., 2008) and can exacerbate comorbid 
conditions (Colten & Altevogt, 2006), placing a significant burden on US health care system. 
 The US Preventative Task Force, the American Academy of Family Physicians, and the 
Center for Disease Control have not made recommendations for OSA screening or assessment 
(Senthilvel et al., 2011). No OSA practice guidelines have been released from any major internal 
or family practice organizations regarding screening and assessment. This demonstrates that sleep 
is undervalued in healthcare. The 2014 American College of Physicians summary includes use of 
screening questionnaires for individuals with unexplained daytime sleepiness (Qaseem et al., 
2014). However, daytime sleepiness is often not reported by patients with OSA and screening for 
other symptoms is warranted (Bailes et al., 2009).  
New Healthy People 2020 guidelines (2015) were released by the Office of Disease 
Prevention and Health Promotion and “Sleep Health” was listed as a national priority. Three 
objectives that are pertinent to improving health outcomes in persons with OSA are: (SH-1) 
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increasing the proportion of persons with symptoms of OSA who seek medical attention; (SH-2) 
reduce the rate of vehicular crashes per 100 million miles traveled that are due to drowsy driving; 
and (SH-4) increasing the proportion of adults who get sufficient sleep (Office of Disease 
Prevention and Health Promotion, 2015). With PCPs managing chronic conditions and acute 
events, there is often inadequate time for screenings that are not recommended (Sorscher, 2008). 
Awareness of the long-term impact of undiagnosed OSA on the cardiovascular system needs to 
stimulate increased OSA screenings in primary care.  
 Multiple treatment options for OSA have been shown to improve quality of life in 
patients with high adherence levels; however, positive airway pressure (PAP) therapy is 
considered the first line treatment for moderate to severe OSA (American Sleep Apnea 
Association, 2015). The AASM recommends using PAP therapy to reduce levels of daytime 
sleepiness and improve patients’ quality of life (Aurora et al., 2015). Understanding the benefit of 
OSA treatments highlights the importance of screening for the sleep disorder.  
This state of the science integrative review aimed to evaluate the screening and 
assessment for OSA in primary care settings including the psychometric properties of OSA 
screening measures. This paper is the first to focus on this issue. A critical evaluation of the 
current state of the science is provided as well as recommendations for future interdisciplinary 
research.  
Methods 
An electronic literature search was conducted by the authors and a medical librarian 
using the databases of Cumulative index to nursing and allied health literature (CINAL), 
Cochrane, Excerpt medical database (EMBASE), and PubMed. Other relevant publications were 
found via obtained articles. The time frame from January 1991- June 2014 was used to include 
the original article of the Epworth sleepiness scale. Keywords in the literature search included but 
were not limited to: “Obstructive sleep apnea”, “adults”, “sleep-related breathing disorders”, 
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“screening”, “assessment”, “primary care”, “primary care providers”, “health care providers”, 
“internal medicine”, and “OSA screening tools”.  
Specific journal articles were included in the literature review based on the following 
criteria: 1. published in the English language, 2. participants studied in primary care 
setting/internal medicine, 3. providers practicing in primary care/internal medicine, 4. included an 
OSA screening process, 5. compared OSA screening tools, and 6. used OSA assessment criteria. 
Studies were excluded if: 1. conducted in any setting other than primary care/internal medicine, 2. 
focused on sleep disorders other than OSA, 3. discussed long-term management of OSA in 
primary care settings, 4. focused on management of OSA patients by sleep physicians, and 5. 
used children as participants. Adult OSA screening in primary care and internal medicine settings 
is the focus of this article because early detection of the sleep disorder can improve health and 
reduce risk of cardiovascular diseases. PCPs often see patients on a regular basis, allowing time 
to screen and assess for risk of chronic health conditions.  
Search Results 
In the initial search, 2,869 records were found. After deleting 553 duplicates, 2,316 
records remained. Relevant articles were reviewed by the first author and the medical librarian 
and verified by the second author from the following databases: 63 in CINAL, 0 in Cochrane, 804 
in EMBASE and 1,450 in PubMed. After implementing the exclusion criteria, 17 articles met 
criteria for this integrative literature review (Figure 1).   
Definitions 
Obstructive sleep apnea  
Essential features of OSA include a repetitive partial (hypopnea) and/or complete (apnea) 
obstruction of the upper airway, marked by upper pharyngeal collapse with continuing efforts to 
breathe (Berry et al., 2014). These events can last 10 seconds or up to a minute in duration, and 
result in intermittent desaturations in oxyhemoglobin levels and sleep fragmentation. In obese 
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individuals, obstructive events in REM sleep have been associated with lower oxyhemoglobin 
desaturations (Peppard et al., 2009). 
An AASM task force listed symptoms of OSA as loud snoring between apneas, witnessed 
episodes of gasping for air, choking, and the presence of daytime sleepiness. The severity of OSA 
is categorized as an individual’s Apnea Hypopnea Index (AHI), which indicates how many times 
an hour the patient experiences obstructive events during polysomnography (PSG) testing 
(Epstein et al., 2009). AHI levels range from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30 ), to 
severe (≥ 30 ) (Berry et al., 2014; Epstein et al., 2009; Guilleminault et al., 2007). Daytime 
excessive sleepiness, fatigue and feeling unrefreshed after sleep are common in most individuals 
with OSA and symptoms are exacerbated by more frequent apnic and hypopnic events (Epstein et 
al., 2009), these can be detected using sensitive and specific screening methods. 
Screening 
Screening for OSA needs to take place in any adult who reports OSA symptoms (Table 
1) (Epstein et al., 2009). The definition for screening is “the act of doing a test on a person… to 
look for evidence of a disease” (Merriam-Webster Dictionary, 2014b). In primary care settings, 
the patient will most likely be screened by a mid-level provider (nurse practitioner and/or 
physician’s assistant) or physician to determine if he/she is experiencing OSA symptoms. OSA 
screening currently takes place via the review of systems process but providers often do not 
include questions to detect sleep disturbances (Grover et al., 2011; Senthilvel et al., 2011). 
Screening needs to occur during a routine health maintenance assessment or as part of a 
comprehensive exam for high-risk patients (Epstein et al., 2009). Physiologic characteristics that 
place a person at high-risk of OSA are listed in Table 2.  
PCPs need to focus on signs and symptoms of sleep disturbances while conducting their 
review of systems (Epstein et al., 2009). If the patient reports these symptoms, occupation should 
be addressed. The Federal Motor Carrier Safety Administration has not released regulations for 
OSA screening (Hartenbaum, 2010), but a recent expert review board recommended further 
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evaluation of any commercial driver with a body mass index (BMI) of 33 or higher (Federal 
Motor Carrier Safety Administration, 2008). An OSA screening measure can be used to predict 
OSA and to determine whether an assessment is warranted. A progressive model of care in 
Australia involved early referral by PCPs of symptomatic high-risk patients to sleep specialists 
(Mansfield, Antic, & McEvoy, 2013). Increased detection of OSA will lead to higher demand for 
sleep specialist services in the US. Mid-level providers can be trained to specialize in sleep 
disorders accommodate for the influx of patients. 
The AASM Clinical Guidelines Task Force (2009) reached “consensus” that several 
questions can be asked by the PCP during routine health maintenance assessments. Asking about 
a history of snoring and daytime sleepiness lacks reliability and validity and has not resulted in 
increased referrals to sleep specialists. PCPs need to use a sensitive and specific measurement to 
identify symptomatic, high-risk patients for referral to a sleep specialist.  
Measurement 
OSA screening measures have been developed to aid health care providers in quickly 
screening patients for moderate to severe OSA in a variety of health care settings (Abrishami et al., 
2010; Ramachandran & Josephs, 2009; Silva et al., 2011). Using sensitive and specific screening 
measures offers a cost-effective way to predict the presence of OSA and highlights the need to refer 
the patient to a sleep specialist. Measures with high positive predictive value are likely to predict 
the presence of a disease while those with high negative predicative values are likely to predict the 
absence of the disease. Screening measurements with extensive validation studies are discussed in 
this review. See Table 3 for detailed psychometric information on the most widely tested OSA 
screening measurements.  
Berlin questionnaire. The Berlin questionnaire (1999) was developed by primary care 
and pulmonary physicians to predict the presence of OSA. The measurement has three symptom 
categories; the first has five unique questions concerning frequency (rare to often) of snoring and 
apneas while sleeping. The second category has four unique questions concerning daytime 
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sleepiness with a question about sleepiness while driving. A score is positive for category 1 and 2 
when a patient selects two responses from the top levels. The third category has two questions. A 
positive response is when a patient has high blood pressure (> 140/90mmHg) or a BMI > 
30kg/m2. After scoring, the individual is considered to be high-risk if two or three of the 
categories are positive. The measurement was compared to home PSG testing; internal reliability 
testing showed category 1 (snoring) was acceptable but Category 2 (daytime sleepiness) was low 
(Netzer et al., 1999). Chung et al. (2008b) and El-Sayed (2012) found this questionnaire to have 
higher levels of sensitivity when compared to specificity. Netzer et al. (1999) reported 
inconsistent sensitivity and specificity levels. Low sensitivity and inconsistent levels of positive 
and negative predicative values are limitations (El-Sayed, 2012; Netzer et al., 1999). This OSA 
screening measure has documented psychometric properties in primary care settings (Chung, 
2011).   
Epworth sleepiness scale. The ESS (1991) was developed as a simple measure to 
quantify the level of daytime sleepiness in adults. The ESS is a brief scale that asks the subject to 
rate on a scale of 0-3 (0=none, 3=high chance of dozing) the level of sleepiness during eight daily 
activities. The sum of the eight questions is calculated and the higher the sum, the higher the 
sleep deficit (0-24). A score of ≥16 indicates a high level of daytime sleepiness (Johns, 1991). 
The ESS has been shown to be reasonably reliable in the test-retest sense, have high internal 
consistency (Johns, 1992), and inconsistent sensitivity and specificity values (El-Sayed, 2012; 
Silva et al., 2011). El-Sayed (2012) reported that the ESS has high positive predictive values but 
lower negative predictive values. The ESS has been used by PCPs to identify patients with 
daytime sleepiness (Silva et al., 2011). This may be problematic if used alone because OSA 
severity does not always correlate with symptomatic sleepiness (Ramachandran & Josephs, 
2009).  
 STOP and STOP Bang Measurements. The STOP is an OSA screening measure that 
was developed to quickly and concisely screen for OSA in a pre-surgical population. The four 
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OSA predictor variables are snoring, tiredness, obstruction and high blood pressure on a Yes/No 
scale (Chung et al., 2008a). A pilot study found that the STOP questionnaire was effective in 
identifying patients with OSA, but the addition of four variables (BMI > 35kg/m, age >50 years 
old, neck circumference > 40 cm, and male gender) increased the sensitivity of the measurement 
(Chung et al., 2008a; El-Sayed, 2012; Silva et al., 2011).  
The new variables were added to the measurement, creating the eight “yes/no” question 
acronym STOP Bang (Chung et al., 2008a; Chung et al., 2012). The person is given one point for 
each “yes” response. Scores range from 0 to 8, with ≥3 indicating a positive screen. El-Sayed 
(2012) reported that the sensitivity of the STOP Bang stayed consistent from the previous STOP 
version. Higher scores have been shown to correlate with the individual’s OSA severity (AHI>5, 
sensitivity 0.836, AHI>15, sensitivity 0.923, AHI>30, sensitivity 1.0) (Chung et al., 2008b). Data 
are limited on the reliability of the STOP Bang in primary care settings.   
With the differences in patient populations, demographics, and ethnicities, scientists must 
be mindful of the limitations of the psychometric data.   
  Assessment 
A more comprehensive sleep history is recommended when an OSA screen is positive or 
the physician determines that further assessment is warranted (Epstein et al., 2009). Assessment is 
defined as “the act of making a judgment about something” (Merriam-Webster Dictionary, 
2014a). No clinical measurement or assessment is absolutely predictive of the presence of OSA, 
but patients deemed high-risk for the disorder should trigger a referral to a sleep specialist for 
further evaluation (Epstein et al., 2009).  
Assessments recommended are BMI, neck circumference, blood pressure, and a visual 
examination of the oro-naso-pharynx. Determining a Mallampati score is helpful in assessing 
posterior pharyngeal crowding caused by increased upper airway soft tissue or abnormal facial 
structures. Higher scores have been correlated with OSA severity (r= 0.351, p= 0.008) and may 
predict nighttime obstructive events. A class 1 Mallampati score is visualization of the entire soft 
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palate; severity ranges to a class 4, which is the inability to see any part of the soft palate. A 
referral to a sleep specialist is indicated when the health care provider determines the patient is at-
risk for OSA (Epstein et al., 2009).  
The assessment for OSA should include an examination of the cardiovascular and 
respiratory systems (Epstein et al., 2009). Untreated OSA can occur in persons with hypertension 
(Walia et al., 2014), along with other conditions such as stroke (C. Chen et al., 2015) and Type II 
diabetes (Wang et al., 2013). Untreated OSA in presence of dilated cardiomyopathy or ischemic 
heart disease can lead to the development of congestive heart failure (D. J. Gottlieb et al., 2010). 
Patients with severe untreated OSA, who also have chronic obstructive pulmonary disease, are at 
higher risk of developing pulmonary hypertension and cor pulmonale. When screening and 
assessment indicate that a patient found is at high-risk for OSA, their referral process must be 
expedited for timely diagnosis and treatment (Epstein et al., 2009). 
Findings 
This state of the science integrative review aimed to evaluate the screening and 
assessment for OSA in primary care settings including the psychometric properties of OSA 
screening measures. The literature published in this area consists of 14 non-experimental and 3 
experimental designs (Table 4). All studies were conducted in the US unless otherwise stated.  
Non-Experimental Designs 
Cross-sectional descriptive studies. Seven studies aimed to screen undiagnosed, high-
risk populations for presence of OSA symptoms. Five studies focused on the importance of early 
screening in high-risk patient populations in several countries (Alam, Chengappa, & Ghinassi, 
2012; BaHammam, Alrajeh, Al-Jahdali, & BinSaeed, 2008; BaHammam, Al-Rajeh, Al-Ibrahim, 
Arafah, & Sharif, 2009; Burgess et al., 2013; Haponik et al., 1996; Netzer et al., 2003). One 
Israeli primary care office developed a symptom checklist to assess PCPs awareness of OSA 
during patient interactions (Reuveni et al., 2004). Burgess et al.(Burgess et al., 2013), used a two 
channel OSA screening device in Australia. 
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 BaHammam and colleagues (2009), reported a 39% prevalence of severe OSA 
symptoms in middle aged Saudi women and 33.3%  in middle aged Saudi men (BaHammam et 
al., 2008) using the Berlin questionnaire. Netzer et al. (2003) performed a standardized survey of 
primary care patients to assess OSA risk factors and symptom frequency in a variety of countries 
(US, Germany, Spain). The survey results indicated that adults in the US had a higher likelihood 
of being at high-risk compared to adults in the European countries. Alam and colleagues (2012) 
screened primary care patients with severe mental illness for OSA using the STOP Bang and 
ESS. A high percentage of the patients with severe mental illness screened positive for OSA 
using the STOP Bang when compared to the ESS. The majority of patients screened as high-risk 
for OSA had never discussed the disorder with their PCP (Alam et al., 2012).    
Burgess et al. (2013) used an unattended 2- channel OSA screening device, called 
ApneaLink+O2, in high-risk patients. A high diagnostic accuracy was found in the OSA moderate 
to severe range compared to PSG. Haponik et al. (1996) used medical interns to pose as primary 
care patients. The histories taken by PCPs were analyzed to determine if unsolicited questions 
were asked regarding snoring, non-restorative sleep, day time sleepiness, or witnessed apneas. 
PCPs did not ask about signs of OSA or educate the patients on risk factors for the disorder 
(Haponik et al., 1996).   
Reuveni et al. (2004) assessed the awareness level of OSA symptoms in PCP in Israel by 
providing standardized patient scenarios to indicate the need for further sleep disordered 
breathing assessment. PCPs understood the algorithms for diagnosis of the disorder but could not 
identify patients in need of diagnosis and treatment. The authors recommended development of 
educational programs to increase PCP’s knowledge of OSA (Reuveni et al., 2004).   
Overall, the studies were consistent in reporting OSA symptoms and risk factors in 
primary care patients. PCPs often encounter patients who are in need of further assessment, 
diagnosis, and treatment but for various reasons, are referred to a sleep specialist.  
35 
PSYCHOMETRIC PROPERTIES 
Retrospective studies. Four studies were found that retrospectively examined OSA 
screening and assessment in primary care patients. A Canadian study used prospective and 
retrospective methods and encouraged participants to complete a sleep symptom checklist to 
discuss with their health care provider during a sleep screening process. Researchers followed-up 
after one year and found that 13.6% accepted further sleep evaluation and completed overnight 
PSG (Bailes et al., 2009). One retrospective chart review evaluated what sleep history questions 
were asked during the screening process. Kramer et al. (1999) found that only a small group of 
physicians ordered sleep studies and the patients that were referred tended to be obese and to have 
overt OSA symptoms. Sorscher (Sorscher, 2008) used a health database to determine if family 
medicine physicians asked sleep disorder questions such as hypersomnolence and sleep 
disordered breathing, insomnia, and parasomnias. Family medicine clinics didn’t screen for sleep 
disorders as often as lifestyle/behavioral issues.  
An Australian population-based survey described the prevalence of persons visiting their 
primary care physicians for insomnia and/or OSA symptoms. , A population-weighted prevalence 
for reporting a doctor visit for snoring/sleep apnea symptoms was 6.2% (Bartlett et al., 2008).  
In summary, most of the studies found that PCPs rarely screen for OSA symptoms 
without prompting from the patient (Bailes et al., 2009; Bartlett et al., 2008; Sorscher, 2008). 
When screening did occur, very few patients were referred to a sleep specialist and many 
mentioned symptoms without follow-up from health care providers (Kramer et al., 1999).   
Correlational descriptive studies. Two correlational descriptive design studies used at 
least one OSA screening measurement (Berlin questionnaire, Cleveland sleep habits 
questionnaire, ESS or STOP) to help identify patients who were at high-risk (Demede et al., 
2011; Senthilvel et al., 2011). Senthilvel et al. (2011) found that only one of the 111 subjects was 
suspected of having OSA by the blinded physicians. The PCP’s did not routinely screen for OSA, 
which may have been influenced by lack of time and reimbursement. The authors suggested PCP 
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use valid and reliable measurements to screen for OSA to better identify high-risk patients 
(Senthilvel et al., 2011). 
Demede et al. (2011) studied the prevalence of resistant hypertension in African-
American patients and determined if they were at high-risk for OSA using the ESS via an Apnea 
risk evaluation system. Patients with resistant hypertension were at 2.5 times higher risk for OSA 
than those with treatable hypertension; conclusions were that comorbid conditions are a public 
health concern in African-Americans. Diagnosing and treating patients with OSA reduces 
cardiovascular risk and improves outcomes for persons with resistant hypertension (Demede et 
al., 2011; Dernaika, Kinasewitz, & Tawk, 2009). 
Mixed method study. Mold et al. (2011) used a mixed method design to determine the 
proportion of primary care patients at high-risk for OSA, the methods used by primary care 
clinicians to identify them, and the proportion of those at high-risk who were diagnosed and 
treated. Primary care offices were randomly selected in five US states to conduct physician and 
patient interviews/assessments using the Berlin questionnaire and chart audits. Sleep consultants 
were also interviewed to discuss referrals for OSA diagnostics. Findings were that OSA patients 
were more accurately detected with the Berlin Questionnaire. Less than 25% of the PCPs 
screened patients routinely for OSA using a review of systems method. According to the PCP 
qualitative interviews, 84% of patients referred to a sleep specialist were positive for OSA. 
Findings from this study indicate that 70-99% of primary care patients who were referred to a 
sleep specialist had untreated severe OSA. This study exemplifies scientific rigor in sleep 
research. 
Overall, these studies reported that PCPs often did not detect OSA symptoms. Screening 
measures used in the studies assisted the PCPs in identifying at-risk patients (Demede et al., 
2011; Senthilvel et al., 2011). 
Experimental Designs.  
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The authors identified three experimental design studies that used different 
methodologies. Both Grover et al. (2011)  and Namen et al (1999) used a prospective, two-group 
design. Grover et al (2011) studied adults undergoing preventative exams at family medicine 
clinics and determined whether a review of systems form identified sleep complaints. 
Approximately one-third of participants reported sleep problems on the review of systems form 
and less than one-fourth of complaints were documented by the PCPs. The review of systems 
form identified persons with OSA when used as a screening measure but few sleep complaints 
were investigated by PCPs. Namen et al. (1999), studied the frequency of sleep history 
documentation and assessed whether randomized chart reminders prompted physicians to conduct 
sleep histories. Each of the physicians were randomly assigned one chart with a sleep history 
prompt and one without. The chart reminders increased the number of documented sleep histories 
but sleep disturbance reports did not impact diagnosis or treatment of the patients’ disorders.  
Ball et al. (1997) aimed to increase recognition of sleep disorders by PCPs in rural 
western US via patient questionnaires, PSG, and chart reviews. The researchers held a training 
session for PCPs taught by sleep specialists, who then taught PCPs how to interpret sleep testing 
data. Prior to the intervention, few charts had documentation of a sleep-related condition. Post 
intervention, the majority of PCPs ordered PSGs for their patients. Using sleep specialists to train 
rural PCPs in sleep medicine is an example of a cost -effective way to use interdisciplinary 
teamwork to increase access to OSA diagnostic testing.  
Overall, these studies demonstrated that interventions that used a review of systems form 
or chart reminders can increase documentation of sleep complaints. Likewise, specialized sleep 
training for PCPs may increase referrals for sleep consultations and PSGs.    
Discussion 
This integrative review will now discuss the strengths, limitations, and implications 
related to the state of the science of screening and assessment for OSA in primary care settings 
including the psychometric properties of OSA screening measures. The strengths of the literature 
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are the overall consensus that there needs to be routine screening and assessment for OSA in 
primary care settings. The results support findings that OSA is associated with exacerbation of 
comorbid conditions and risk for increased mortality and morbidity (Alam et al., 2012; 
BaHammam et al., 2008; BaHammam et al., 2009; Ball et al., 1997; Burgess et al., 2013; 
Haponik et al., 1996; Mold et al., 2011; Netzer et al., 2003). The authors conclude that there is a 
lack of recognition of OSA symptoms by PCPs, whether or not the patient complains of daytime 
sleepiness (Bailes et al., 2009; Bartlett et al., 2008; Namen et al., 1999; Sorscher, 2008). Even 
more concerning is the agreement that PCPs are aware of the need to improve cardiovascular 
health, but aren’t proactive in screening and assessment for OSA (Demede et al., 2011; Grover et 
al., 2011; Kramer et al., 1999; Reuveni et al., 2004; Senthilvel et al., 2011). This may be because 
screening measures need to demonstrate higher sensitivity, specificity, and predictive values 
before PCPs will adopt them. Findings report inconsistent psychometric findings for OSA 
screening measures with a lack of validation research in primary care (Abrishami et al., 2010; El-
Sayed, 2012; Ramachandran & Josephs, 2009; Silva et al., 2011). PCP must recognize the 
importance of referrals to sleep specialists to earlier diagnose and treat OSA and improve patient 
outcomes. Overall, this review showed that the current practice model of screening and 
assessment for OSA in primary care is fragmented and ineffective.  
 This state of the science on screening and assessment of OSA patients in primary care 
settings is not without limitations. Not all OSA screening measurements that have been reported 
to be reliable and valid in primary care settings were included. Some studies may have been 
missed during the literature search process. No studies reported information on patients’ 
willingness to be referred to sleep specialists. Lastly, several included studies did not explicitly 
state the research design and only one used participant randomization.  
Implications for Research  
Currently, there is no guideline for OSA screening in primary care. Studies are needed to 
further test a review of systems form or chart reminders. Inadequate screening is due in part to 
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inconsistent psychometric results from current OSA screening measures. More validation testing 
of the OSA screening measures is needed in primary care before a conclusion can be made 
regarding which tool has the best OSA predictability. Before a guideline can be developed, the 
OSA measurements used in primary care need to have high levels of sensitivity, specificity, and 
positive predictive values to reliably screen patients for OSA. The testing of OSA screening 
instruments must be conducted in large-scale, nationwide, studies that assess implementation in 
primary care settings. Considerations for a reference standard might include identification of 
adults with signs and symptoms, or conditions, associated with high risk for OSA. The 
development of an OSA screening guideline might reduce cardiovascular mortality in at-risk 
patients as long as the patient is adherent to the prescribed treatment. This is an area where 
research can have a large impact on cardiovascular health nationwide.  
The AASM (2015) has recommended the integration of screening for sleep disorders in 
the Electronic medical record (EMR) as a health care priority. A task force is currently 
developing a series of sleep-related data fields. Future screening and assessment protocols may be 
integrated into the EMR to standardize the process. Translational research needs to provide 
evidence for using the EMR as a database for OSA screening and referrals from PCPs to sleep 
specialists.  
Conclusion 
Screening and assessment for OSA needs to be a priority in primary care settings. PCPs 
need to use measurements that accurately predict the presence of OSA. The STOP Bang and 
Berlin questionnaires serve as the current best measures to predict the presence of moderate to 
severe OSA (Ramachandran & Josephs, 2009; Silva et al., 2011). The ESS is a measure of 
daytime sleepiness (Johns, 1991) that can be used to help determine the level of daytime 
impairment. The STOP Bang and the Berlin questionnaires have the highest sensitivity of the 
measurements studied but at the expense of specificity (El-Sayed, 2012). The measurements do 
not perform well at excluding low risk for OSA. It is unclear at this time due to inconsistencies of 
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the psychometric properties which screening measure best predicts OSA in the primary care 
setting. More research is needed to determine psychometric properties of OSA screening 
measurements in primary care. The results from these studies can be translated into practice to 
better detect OSA in primary care patients.   
PCPs need to be educated on how to detect OSA and its long-term effects on 
cardiovascular morbidity and mortality. Increased use of reliable and sensitive OSA screening 
tools in primary care will lead to earlier and more frequent detection of the sleep disorder and to a 
higher demand of sleep specialists’ services. More mid-level providers (nurse practitioners and 
physician assistants) will need to be trained in sleep medicine to care for the influx of patients.  
It is important to diagnose and treat OSA and cardiovascular disease as co- morbid 
conditions. By screening and assessing patients who are at risk for OSA in primary care settings, 
cardiovascular outcomes may stabilize and/or improve. Few studies have reported the screening 
and assessment process of OSA in primary care settings. The current state of the science will 











































1. Adults often present with signs and symptoms or conditions associated with 
high risk for OSA but are not screened, assessed, or referred to a sleep 
specialist for diagnosis and treatment. 
 
2. When an OSA screen is positive recommendations are to assess BMI, neck 
circumference, blood pressure and Mallampati score. 
 
3. Reliable and valid measurements offer a cost effective way to screen for 




1. Conduct more validation testing of the OSA screening measures in primary 
care before a conclusion is made of which tool has strongest predictability 
2. Develop an evidence-based OSA screening guideline to promote earlier 
detection of the disorder. 
3. Determine whether embedding OSA screening and assessment guideline in 
the EMR results in increased number of patients screened, assessed, 
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OSA Signs and Symptoms 
a. Snoring 
b. Witnessed apneas 
c. Nocturnal gasping/choking 
d. Unexplained daytime sleepiness 
e. Large neck size (≥ 17 inches for men, ≥ 16 inches for women) 
f. Sleep fragmentation/insomnia 
g. Non refreshing sleep  














































 Conditions Associated with High Risk of Obstructive Sleep Apnea 
a. Obesity (BMI>35) 
b. Cardiac or metabolic comorbid conditions (congestive 
heart failure, atrial fibrillation, hypertension, Type 2 
Diabetes, nocturnal cardiac dysrhythmias, stroke, 
pulmonary hypertension) 
c. Pre-operative bariatric surgery 
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OSA Screening and Assessment Practices in Primary Care 
Author Purpose Participants Measurement Results 
Non Experimental Designs 
Cross-sectional Descriptive Studies 
Alam et al. 




screening of OSA 





illness in PC clinic 
(n=100) 
STOP Bang and ESS 69 patients screened positive 
for OSA using STOP Bang; 20 
using ESS; 68 patients in high-
risk group reported  OSA was 






of individuals who 






Berlin questionnaire 192 males were high risk. 
Symptoms included; 
BMI>30kg/m2 (n=153), HTN 
(n=101), snoring (n=302), 
apnea>3 times/week (n=30), 
daytime sleepiness >once/week 
(n=205), and sleeping while 







symptoms and risk 
of OSA in women  
Middle aged Saudi 




into three categories 




156 women were high risk. 
Symptoms included; HTN 
(n=99), BMI > 30 (n=228), 
snoring (n=163), 
apnea>3times/week (n=90), 
day time sleepiness>1x/week 
(n=210), falling asleep in car 
(n=130). 




al. (2013).13  
Australia 
Determine 
feasibility of using 
an unattended 2-
channel device for 
OSA screening in 
a population of 
high-risk patients 
Adult patients at 




ESS Device results: AHI > 5 
(n=821), AHI > 15 (n=382), 
and AHI >30 (n=185). 81 were 
unable to use accurately. 
Haponik et 
al. (1996). 57 
United States 
Determine how 
often sleep history 
was obtained prior 










trained to volunteer 
sleep problems if 
asked by the PCP  
3 interns inquired about sleep 
problems but questions were 
not asked regarding snoring, 
non-restorative sleep, 
hypersomnia, and witnessed  
apnea. 18 interns asked 
questions more often. 





Spain   
Standardized 




OSA, c. composite 




(n=6,223) in 40 
offices and clinics 
in US (n=26), 
Germany (n=8) 
and Spain (n=6) 
Used Berlin 
questionnaire, 
collected BMI, age, 
and sex.  
Participants in US had higher 
probability of OSA vs. Europe 
and men > than women. 
Obesity rate was > in U.S vs. 
Europeans.   
 
Reuveni et 
al. (2004).58  
Israel 
Assess OSA 










Used an investigator 
developed patient 
questionnaire and 
incorporated it into 
PCPs practice.  
3 PCPs asked ≥ three sleep 
questions, 3 asked two 
questions, 9 asked 1 question, 
15 asked no questions. 
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Retrospective Studies  






to a successful 
sleep clinic 
referral. 
Two samples a. 






by patients who stated 
which symptoms they 
discussed with 
physicians in past 
year, followed up 
with PSG referral. 
PSG completers had higher 
AHI. Sleep clinic patients 
reported more sleep symptoms 
and explained symptoms 
directly. 










Adult PC patients 
(n=1421, 18-24 
year olds) and 
(n=1879, 25-65 
year olds).  




safety/fatigue), b. 1 
Question from 
Pittsburg Sleep 
Quality Index/ESS, c. 
OSA/insomnia 
questions, and d. 
medical exam.  
2.9% of weighted respondents 
reported visiting their doctor 
for insomnia and OSA. Older 
patients reported more OSA 
symptoms to PCP (n=133). 




of patients referred 







Determine if PCP 
asked questions on 
Patients (=69) 
referred to hospital 
based sleep center 





65 had OSA; of 63 patients 
















inquiry by PCPs 
of unhealthy sleep 
patterns/symptoms 
on questionnaires.  








57% of health history database 
had no sleep health content. 
Two sites had sleep questions; 
one site had a question about 
snoring.   





prevalence of RH 
and whether 
patients are at 





Emanated from the 
Metabolic Syndrome 
Outcome Study. 
ESS via Apnea Risk 
Evaluation System  
52 participants met criteria for 
RH. 80 screened as high risk 
for OSA. Patients with RH 
were at 2.5 times higher risk 
for OSA.  
Senthilvel et 
al. (2011).26  
United States 
Determine if PCPs 






New adult patient 
evaluations  
(n=101) 
PC clinic at 




ESS, and STOP  
25 patients had ≥ one sleep 
symptom and limited sleep 
history. Questionnaires 
identified at risk patients more 
efficiently than PCPs. 9 
patients had sleep disorder 
documentation. 2 were 
referred to sleep clinic.  
Mixed Methods Study 
Mold et al. 
(2011).62 
United States  
Determine 
proportion of PC 
patients at high 
risk for OSA and 
those who have 
been diagnosed 
PC clinics (n=44), 
5 states, sleep 
consultants (n=18) 
chart audits (n= 
1744), patients 
(n=2091, n=1357 




medical records, c. 
data from OSA 
Of 662 younger patients, 299 
discussed symptoms with 
PCP. 283 older patients were 
at risk for OSA and 132 
discussed symptoms with 
PCP. OSA prevalence among 
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and treated as well 
as methods used 
by PCPs to 
identify them. 
ages 30-64, n=734 
age> 65) 




the older adults was between 
12 and 25%.  
   Experimental 
Design 
 
Grover et al. 
(2011).12 
United States 







c. Prevalence of 
patients at  risk for 







exams at family 
practice clinics 
(n=2) 
ROS forms and 
Berlin questionnaire  
At site 1, 92 patients reported 
sleep problems on ROS, 22 
complaints were documented. 
82 patients had increased risk 
of OSA. ROS responses were 
57% sensitive and 73% specific 
for increased OSA compared to 
Berlin questionnaire. At site 2, 
1of 20 sleep complaints were 
documented. 
Namen et al. 
(1999).63 






officers and to 











screened for a. 
hypersomnolence b. 
difficulty sleeping c. 
interference with 
daily functioning  
Chart reminders increased 
frequency of sleep histories, 
from 6 to 29% over 3 years. 4 
patients had sleep history 
recorded but had no impact 
management plan.  
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Ball et al. 
(1997).64 
United States  
Enhance 
recognition of 
sleep disorders by 
PCPs; transfer 
diagnostic testing 
and care of 
patients from 













data, and specialized 
reports were used.  
Referrals increased from 2 out 
of 752 cases to 294 out of 
14,330 cases over 2 yrs. CPAP 
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Background/Purpose: Portable sleep monitors (PSM) have increased in popularity due to 
improvements in technology and accessibility. The American Academy of Sleep Medicine 
established guidelines for obstructive sleep apnea (OSA) using PSM. A comprehensive sleep 
evaluation and Level III PSM are required for OSA diagnosis. PSM must include least four 
channels; two respiratory (respiratory movement and airflow), one cardiac (heart rate or 
electrocardiogram), and oxygen saturation. Research studies using PSM have not consistently 
reported procedures and methodological challenges. The first purpose of this paper was to 
synthesize the literature on use of PSM in research of adults in terms of methodological 
challenges, including: (a) participant sampling; (b) instrumentation issues; (c) clinical variables; 
(d) data processing; and (e) patient acceptability. The second purpose was to identify 
methodological strategies to use to standardize PSM information in research reports.     
Methods: The search strategy included studies of participants undergoing sleep testing for OSA 
using PSM. CINAHL, MEDLINE via PubMed, and Embase were search from 2000 to January 
2016; some search terms used were “polysomnography”, “home”, “device(s)’, “level III’, 
“obstructive sleep apnea”, “portable sleep monitors”, and “out of center testing”. Of the 371 
articles retrieved, 338 articles were excluded because Level III PSM were not used; 33 articles 
were included in this focused review.   
Findings: The research articles were inconsistent in reporting methodological challenges. The 
authors identified five criteria to examine. Participants usually included samples who had OSA or 
were suspected of having OSA (n=20). Several different PSM (n=14) were used; the most 
commonly reported instrumentation issue was device malfunction. Almost all studies reported 
clinical variables (n=30). Data processing of the PSM data was discussed in the majority of the 
articles (n=19). Few studies (n=6) reported information on patient acceptability.  
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Conclusion: Ten methodological strategies are suggested for adoption when using PSM in 
research. Future studies need to address the methodological challenges and adopt more consistent 


























Methodological Strategies in Using Portable Sleep Monitoring in Research 
Introduction 
 Obstructive sleep apnea (OSA) in adults has been increasing in prevalence over the last 
two decades in the United States. The increase is attributed in part to the obesity epidemic 
(Peppard et al., 2013). Estimates are that moderate to severe OSA, defined as an apnea hypopnea 
index (AHI) ≥ 15 is present in 10% of men ages 30-49 years, 17% of men ages 50-70 years, and 
9% of women ages 50-70 years. OSA contributes significantly to all-cause (Kendzerska et al., 
2014; Qaseem et al., 2014) and cardiac (Kendzerska et al., 2014) mortality. The gold standard for 
OSA diagnosis is level 1 testing by laboratory polysomnography (PSG). During laboratory PSG 
testing, surface electrodes are positioned to measure electroencephalography, muscle activity, 
heart and respiratory physiology, and ocular movements (Marino et al., 2013). This type of 
testing is recommended in patients with co-morbid conditions such as moderate to severe 
pulmonary disease, neuromuscular disease, congestive heart failure, or suspected to have other 
sleep disorders (central sleep apnea, periodic limb movement disorder, insomnia, parasomnias, 
circadian rhythm disorders, or narcolepsy) (Collop et al., 2007). Because of the increase in OSA 
prevalence, sleep laboratory and diagnostic services are in high demand and alternative methods 
are needed to screen and diagnose sleep disorders.  
In the late 1980’s, clinicians began to recognize the need for ambulatory sleep studies but 
focused on arterial oxygen saturation (CleveMed & Cleveland Medical Devices Inc., 2016). The 
first practice parameters for portable sleep monitors (PSM) were released in 1994 (Ferber et al., 
1994) and indications for PSG testing were published in 1997 (Chesson et al., 1997). At that time, 
most devices measured snoring but did not meet diagnostic requirements for OSA. In 2000, the 
Agency for Healthcare Research and Research Quality (AHRQ) reported results of a meta-
analysis that stated broad use of PSM could not be supported due to insufficient evidence (Ross et 
al., 2000). PSM were further developed to include oxygen saturation, heart rate, oral/nasal 
airflow, respiratory effort and body position (CleveMed & Cleveland Medical Devices Inc., 
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2016). In 2006, the AASM released a statement recommending that physicians who use PSM 
need to conduct a clinical assessment and a comprehensive patient evaluation. Further, PSM 
could only be used by AASM-accredited sleep centers or board-certified sleep physicians and 
treatment needed to be guided by the evaluation of study results and patient symptoms (American 
Academy of Sleep Medicine, 2006; Collop et al., 2007). These recommendations encouraged 
device manufacturers to develop PSM that met recommended criteria for screening and diagnosis 
of OSA in home settings.  
PSM has increased in popularity due to technological improvements and accessibility. 
The Centers for Medicare and Medicaid (CMS) released standards for home testing requiring the 
apnea hypopnea index (AHI) or respiratory distress index (RDI) as mandatory for OSA diagnosis 
by PSM home testing (Department of Health and Human Services & Centers for Medicare & 
Medicaid Services, 2013). AASM created a task force (2007) to develop guidelines for PSM. 
These guidelines state that the diagnosis of OSA needs to be performed with a comprehensive 
sleep evaluation and with monitors that have level III diagnostic capability, including at least four 
channels; two respiratory variables (respiratory movement and airflow), cardiac measurement 
(heart rate or electrocardiogram), and oxygen saturation. The level III monitors must display raw 
data and allow for manual scoring, or editing of automatic scoring, by a sleep professional 
because PSM can underestimate AHI levels compared to PSG (Collop et al., 2007).  
PSM allow patients access to a less expensive diagnostic option that can be completed in 
outpatient settings where sleep technologists are not present (Pereira, Driver, Stewart, & 
Fitzpatrick, 2013). PSM are valuable diagnostic measures for OSA but are not without 
disadvantages. Common issues with PSM include missing data due to equipment failure 
(Nickerson et al., 2015; Pereira et al., 2013) and lower sensitivity and specificity levels compared 
to PSG (Fredheim, Roislien, & Hjelmesaeth, 2014; Guerrero et al., 2014; Polese et al., 2013). 
There has been significant night to night AHI level variability in mild versus moderate OSA, 
when using PSM in home settings (Prasad et al., 2016). Researchers need to be knowledgeable of 
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published literature using level III monitors. Knowledge from this focused review will inform the 
readers regarding methodological challenges that are common with the use of the devices.  
There are two main objectives for this manuscript. The first purpose was to synthesize the 
literature of methodological challenges in using level III PSM in research in adult patents. The 
second purpose was to identify methodological strategies to use to standardize PSM information 
in research reports.      
Methods 
Studies that included participants undergoing home sleep testing for obstructive sleep 
apnea diagnosis using PSM were identified by CINAHL, MEDLINE via PubMed, and Embase 
from the year 2000 to January, 2016. The year 2000 was chosen because literature from Level III 
PSM was not found prior to that date. Appropriate search terms for PSM were investigated by the 
first author. A medical librarian assisted in searching the literature using the following search 
terms: “polysomnography”; “home”; “device(s)”; “sleep disordered breathing”; “level III’; 
“obstructive sleep apnea”; “sleep disordered breathing”; “portable sleep monitors”; “home sleep 
testing devices for obstructive sleep apnea”; “out of center sleep testing”; “portable home sleep 
testing”. Articles included in the review met the following criteria: (a) primary research using 
PSM that reported methods, results, and findings, (c) Level III PSM examined, (c) sample size ≥ 
30 participants, and (d) published in the English language. Studies were excluded if: (a) pediatric 
participants were included and (b) research was retrospective.  
Search results 
Of the 371 articles retrieved, 338 articles were excluded because Level III PSM were not 
used. Relevant articles were reviewed by the medical librarian and the first author and were 
subsequently verified by the co-authors. After implementing the exclusion criteria, 33 articles 
were included in this focused review of PSM.   
Selection of pertinent variables: The authors reviewed the 33 articles and identified five 
challenges when using PSM in adult patients in research. These challenges included;  (a) 
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participant sampling; (b) instrumentation issues; (c) clinical variables; (d) data processing 
methods; and (e) patient acceptability. Challenges were selected because they were the most 
common themes described in the 33 articles. A review of the articles organized by these the 
criteria is presented in Table 1.  
Participant sampling. The sample and study settings were generally homogenous in 
nature and were conducted in a variety of countries. Slightly less than half of the studies 
[45%,(n=15)] had a sample size greater than or equal to 100 subjects (Abdel-Kader et al., 2012; 
Aurora, Swartz, & Punjabi, 2015; Dawson et al., 2015; Dingli et al., 2003; Gonçalves et al., 2007; 
Johansson, Alehagen, Svanborg, Dahlström, & Broström, 2012; Kuna, 2010; Masa et al., 2011; 
Nakayama-Ashida et al., 2008; Pereira et al., 2013; Senchak, Frey, & O'Connor, 2012; Skomro et 
al., 2010; Tedeschi et al., 2013; Tonelli de Oliveira et al., 2009; Weir et al., 2012). One-third 
(n=11) of the studies in this literature review were conducted in the United States (Abdel-Kader 
et al., 2012; Aurora et al., 2015; Dawson et al., 2015; Kuna et al., 2011; Lettieri, Lettieri, & 
Carter, 2011; Michaelson, Allan, Chaney, & Mair, 2006; Nickerson et al., 2015; Reichert, Bloch, 
Cundiff, & Votteri, 2003; Senchak et al., 2012; Su, Baroody, Kohrman, & Suskind, 2004; Weir et 
al., 2012). Studies were conducted in 11 other countries, including: Argentina (Nigro, Malnis, 
Dibur, & Rhodius, 2012), Brazil (Danzi-Soares et al., 2012; Gonçalves et al., 2007; Polese et al., 
2013; Santos-Silva et al., 2009; Tonelli de Oliveira et al., 2009), Canada (Driver et al., 2011; 
Gjevre et al., 2011; Guerrero et al., 2014; Pereira et al., 2013; Skomro et al., 2010), China (H. 
Chen et al., 2009; Yin, Miyazaki, & Ishikawa, 2006), Italy (Maestri, La Rovere, Robbi, & Pinna, 
2011; Tedeschi et al., 2013), Japan (Nakayama-Ashida et al., 2008), Scotland (Dingli et al., 
2003), Spain (Masa et al., 2011), Sweden (Johansson et al., 2012; Zou, Grote, Peker, Lindblad, & 
Hedner, 2006), Taiwan (Yeh, Lin, Chiu, & Bai, 2015), and Turkey (Yuceege, Firat, Demir, & 
Ardic, 2013).    
Most of the participants were sleep clinic patients who either had or were suspected of 
having OSA [61%, (n=20)] (H. Chen et al., 2009; Dawson et al., 2015; Dingli et al., 2003; Driver 
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et al., 2011; Gjevre et al., 2011; Guerrero et al., 2014; Kuna et al., 2011; Lettieri et al., 2011; 
Masa et al., 2011; Michaelson et al., 2006; Nigro et al., 2012; Pereira et al., 2013; Polese et al., 
2013; Reichert et al., 2003; Santos-Silva et al., 2009; Skomro et al., 2010; Su et al., 2004; 
Tedeschi et al., 2013; Tonelli de Oliveira et al., 2009; Yin et al., 2006). Twelve studies included 
participants who had co-morbidities associated with OSA but met criteria for PSM (Abdel-Kader 
et al., 2012; Aurora et al., 2015; Danzi-Soares et al., 2012; Gonçalves et al., 2007; Johansson et 
al., 2012; Maestri et al., 2011; Nakayama-Ashida et al., 2008; Nickerson et al., 2015; Senchak et 
al., 2012; Weir et al., 2012; Yeh et al., 2015; Yuceege et al., 2013; Zou et al., 2006).   
Instrumentation issues. There were 14 different PSM used in the studies. However, three 
models were used in more than half [55%, (n=18)] of the studies (Aurora et al., 2015; H. Chen et 
al., 2009; Danzi-Soares et al., 2012; Dawson et al., 2015; Dingli et al., 2003; Gjevre et al., 2011; 
Johansson et al., 2012; Kuna et al., 2011; Lettieri et al., 2011; Maestri et al., 2011; Nickerson et 
al., 2015; Nigro et al., 2012; Polese et al., 2013; Santos-Silva et al., 2009; Senchak et al., 2012; 
Skomro et al., 2010; Weir et al., 2012; Yin et al., 2006). Eleven PSM were used in the remainder 
of the studies (Abdel-Kader et al., 2012; Driver et al., 2011; Gonçalves et al., 2007; Guerrero et 
al., 2014; Masa et al., 2011; Michaelson et al., 2006; Nakayama-Ashida et al., 2008; Pereira et al., 
2013; Su et al., 2004; Tedeschi et al., 2013; Tonelli de Oliveira et al., 2009; Yeh et al., 2015; 
Yuceege et al., 2013; Zou et al., 2006). Instrumentation related details included in these studies 
were level of monitor, model, and manufacturer.  
More than half [n=17, (52%)] of the studies reported problems with overnight collection 
of sleep data such as: recordings less than minimum required time  (Nakayama-Ashida et al., 
2008; Nickerson et al., 2015),  lack of air flow recordings (Dingli et al., 2003; Nakayama-Ashida 
et al., 2008; Tonelli de Oliveira et al., 2009; Yin et al., 2006), nasal cannula tube kinking (Driver 
et al., 2011), incomplete pulse oximetry (Yin et al., 2006), battery/download failure (Driver et al., 
2011; Pereira et al., 2013; Polese et al., 2013; Reichert et al., 2003; Skomro et al., 2010), poor 
participant compliance (Maestri et al., 2011; Reichert et al., 2003; Tonelli de Oliveira et al., 
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2009), overall device failure (Nakayama-Ashida et al., 2008; Tedeschi et al., 2013; Yeh et al., 
2015), underestimation of AHI severity compared to PSG (Lettieri et al., 2011), or unstated 
reasons (Guerrero et al., 2014; Kuna et al., 2011; Yuceege et al., 2013). 
 Some studies [n=8, (24%)] reported engaging the participants in education of the PMS 
prior to the release of the device for home testing (Dingli et al., 2003; Guerrero et al., 2014; 
Nickerson et al., 2015; Pereira et al., 2013; Polese et al., 2013; Skomro et al., 2010; Yeh et al., 
2015; Yin et al., 2006). Understanding PSM instrumentation issues is critical to the reliability of 
clinical variables. Data collected in a laboratory setting may have an environmental bias due to 
sleep technician supervision; PSM device failures are more likely to be recognized and corrected.    
Clinical variables. Clinical variables recorded and reported by PSM included AHI, RDI, 
and ODI. AHI is the total number of apneas and hypopneas per hour of sleep. AHI levels range 
from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30), to severe (≥ 30) (Berry et al., 2014; 
Epstein et al., 2009; Guilleminault et al., 2007). When using PSM, RDI is calculated as the 
number of apneas and hypopneas divided by total recording time (Epstein et al., 2009). ODI is the 
number of times per hour of sleep that the oxygen level in the blood drops by greater or equal to 
3% from baseline (Berry et al., 2012).  
AHI, RDI, and/or ODI were reported in 30 studies. The majority [(36%) (n=12] of 
studies calculated and compared AHI levels from PSM to PSG (Abdel-Kader et al., 2012; H. 
Chen et al., 2009; Danzi-Soares et al., 2012; Dingli et al., 2003; Guerrero et al., 2014; Masa et al., 
2011; Polese et al., 2013; Reichert et al., 2003; Santos-Silva et al., 2009; Skomro et al., 2010; 
Tonelli de Oliveira et al., 2009; Yin et al., 2006). Four studies reported RDI and/or ODI (Dawson 
et al., 2015; Driver et al., 2011; Tedeschi et al., 2013; Zou et al., 2006); and two studies compared 
RDI and/or  ODI from PSM to PSG (Pereira et al., 2013; Yuceege et al., 2013). Many studies 
[n=10, (30%)] psychometrically tested PSMs in the sleep laboratory (H. Chen et al., 2009; 
Dawson et al., 2015; Dingli et al., 2003; Driver et al., 2011; Michaelson et al., 2006; Polese et al., 
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2013; Reichert et al., 2003; Santos-Silva et al., 2009; Su et al., 2004; Tonelli de Oliveira et al., 
2009).   
Each study had different research questions however, not all clinical variables were 
compared to PSG. One study compared AHI and RDI levels from PSMs to a device made by 
another manufacturer (Aurora et al., 2015). Another study compared AHI levels from a PSM to 
the Berlin Questionnaire and the Epworth Sleepiness Scale to demonstrate feasibility in military 
pre-deployment assessment (Senchak et al., 2012). Finally, one study compared AHI levels from 
a PSM to acetylcholine receptor antibodies in patients with myasthenia gravis to examine 
predictors for OSA (Yeh et al., 2015).  
Data processing methods. According to the AASM, PSM must allow for the display of 
raw data for manual scoring or be able to be edited by a trained sleep technologist. For diagnostic 
purposes, review of the raw data must be completed by a certified sleep specialist or someone 
who meets eligibility criteria for the sleep medicine certification exam (Collop et al., 2007).  
In this review, 18 of the 33 articles (55%) discussed PSM data scoring methods; however, 
one article did not state whether the data were scored automatically or manually (Kuna, 2010). A 
few studies [n=4, (12%)] used physicians to manually interpret overnight PSM data (Gonçalves et 
al., 2007; Guerrero, Masa, Embid, & Montserrat, 2014; Nigro et al., 2012; Tonelli de Oliveira et 
al., 2009); in two studies (6%) physicians reviewed data after it was manually scored by a sleep 
technician (Aurora et al., 2015; Gjevre et al., 2011). More commonly, studies used sleep 
technicians (Abdel-Kader et al., 2012; Aurora et al., 2015; Driver et al., 2011; Guerrero et al., 
2014; Masa et al., 2015; Pereira et al., 2013; Santos-Silva et al., 2009), research personnel (Dingli 
et al., 2003), employees of PM manufacturers (Michaelson et al., 2006; Su et al., 2004), or 
unspecified persons (Johansson et al., 2012) to manually score data. Only 4 studies used 
automatic scoring techniques to analyze the PSM data (C. Chen et al., 2015; Nigro et al., 2012; 
Su et al., 2004; Yin et al., 2006).   
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Patient acceptability. Six studies (18%) asked participants to evaluate use of PSM. Five 
reported on ease of use and comfort of the PSM (Nickerson et al., 2015; Polese et al., 2013; 
Senchak et al., 2012; Skomro et al., 2010; Yin et al., 2006). Three studies measured sleep quality 
after using PSM (Gonçalves et al., 2007; Skomro et al., 2010; Yin et al., 2006) and two studies 
asked their participants to use sleep diaries (Gonçalves et al., 2007; Skomro et al., 2010). Only 
one study qualitatively measured how participants felt about PSM in terms of importance of OSA 
testing, ease of use, comfort, and if the participants understood how the monitor worked 
(Nickerson et al., 2015).  
When analyzing research studies that used PSM as methodological instrument, it is 
important to understand the study’s sampling, instrumentation issues, clinical variables, data 
processing methods, and patient acceptability. These topics are vital considerations when 
designing research studies using PSM.    
Methodological Strategies for Using Portable Sleep Monitors in Research 
There are many challenges when using PSM in research. Understanding and addressing 
the challenges when designing a research study is vital to obtaining full sets of data and achieving 
an accurate analysis of the clinical variables. Consistent standards of publishing can lead to easier 
comparability of results across studies. Clinical guidelines for the use of PSM in the diagnosis of 
OSA have been established (Collop et al., 2007) and should be used as a model when designing 
validation studies. Based on findings from the review, this section identifies methodological 
strategies to use to standardize PSM information in research reports (Table 2). Strategies were 
organized into five areas: participant sampling, instrumentation issues, clinical variables, data 
processing methods, and patient acceptability.   
Participant sampling 
 Suggestion 1. Co-morbid conditions must be taken into account when selecting 
inclusion/exclusion criteria. According to the AASM task force, PSM testing is not appropriate 
in patients with significant co-morbid conditions (moderate to severe pulmonary disease, 
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neuromuscular disease, or congestive heart failure) due to the degradation of data accuracy. 
Likewise, PSM testing is not recommended in patients suspected of having other sleep disorders 
(central sleep apnea, periodic limb movement disorder, insomnia, parasomnias, circadian rhythm 
disorders, or narcolepsy) (Collop et al., 2007). Patients with these co-morbid conditions must 
receive laboratory PSG testing under direct supervision of a certified sleep technician in order to 
establish an OSA diagnosis.  
 Suggestion 2. Instruct participant on his/her role in data collection, such as wear 
time and recordings on specific days of the week. Each individual has a unique sleep schedule 
and patterns may vary depending on weekdays, weekends, and work schedules. Some participants 
may be hesitant to engage in research studies that include PSM because they have busy work and 
life schedules and changes in sleep habits may affect their level of daytime functioning. Some 
participants may engage in more social activities on the weekend that may include alcohol 
consumption, which increases the likelihood of pharyngeal collapse and apneic/hypopneic 
episodes. Consistency in assigning the same days, when feasible, is suggested to reduce 
variability and the length of recording time needed to analyze sleep data. The researcher is 
responsible to explain the importance of adequate wear time to reduce the amount of missing 
data.  
Instrumentation issues 
 Suggestion 3. Monitors should be at least level III and include a minimum of four 
channels. Portable sleep testing has evolved over time and involves a wide range of available 
technology. Types of testing can range from the most thorough laboratory PSG (level I) which 
typically records nine physiologic channels (electroencephalogram, electrooculogram, 
electrocardiogram, chin electromyogram (EMG), limb EMG, respiratory effort at 
thorax/abdomen, airflow from nasal cannula, pulse oximetry, and ability to monitor continuous 
positive airway pressure or bi level positive airway pressure) to the least thorough unattended 
portable device, with two channels (oxygen saturation and airflow) (CleveMed & Cleveland 
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Medical Devices Inc., 2016). Monitors used in research should be at least level III capabilities 
with at least four channels, including: two respiratory variables (respiratory movement and 
airflow), cardiac measurement (heart rate or electrocardiogram), and oxygen saturation. Some 
PSM have features that record snoring, detect light, or can sense changes in body position; 
however, these channels are not mandatory for diagnostic testing (CleveMed & Cleveland 
Medical Devices Inc., 2016; Collop et al., 2007). 
 Suggestion 4. Cost of PSM supplies should be considered when designing a study. 
For research purposes, most PSM are available for rent (policies and cost differ between 
suppliers/ companies/ models / manufactures). Along with funding for the sleep monitor, 
researchers must take into account the purchase of the sensors that attach to the device, which 
vary depending on the model (typically nasal cannulas, oxygen probes, batteries, abdominal 
belts). All PSM used in the research study should be of the same type and model to ensure the 
validity and reliability of the data.  
Clinical variables 
 Suggestion 5. AHI or RDI must be reported as the outcome variable from the PSM. 
Reporting of the AHI or RDI after PSM is mandatory for OSA diagnosis and reimbursement by 
Medicare & Medicaid standards; ODI may be reported but is not considered diagnostic for OSA 
(Department of Health and Human Services & Centers for Medicare & Medicaid Services, 2013).  
 Suggestion 6. Provide definition(s) of outcome variable(s). It is important for 
researchers to provide clear operational definitions of the variables being measured in order to 
compare findings and clinical applications. Providing definitions for AHI, RDI, or ODI orients 
the reader to the physiological importance of the data. 
Data processing methods 
 Suggestion 7. Researchers must determine how PSM data will be stored, analyzed, 
and reported when designing the study. Many models of PSM may be used repeatedly, as the 
data can be stored, the device cleaned, and released quickly to a new participant. One of the 
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challenges is determining how data will be stored after use and how/who will analyze it. Prior to 
beginning the study, researchers need to identify secure places for data storage and accessibility 
according to IRB regulations/criteria. Once the PSM data is downloaded and stored in a secure 
area, many manufactures provide programs that allow for automatic or manual scoring. AAMS 
states that the PSM must display raw data and allow for manual scoring or editing of automatic 
scoring by a sleep professional (Collop et al., 2007). Automatic scoring is completed by 
downloading the PSM data to the manufacturer’s software program that analyzes the data. 
Manual scoring must take place by a sleep professional who has been trained in scoring raw sleep 
data (sleep technologist or board certified sleep physician) (Collop et al., 2007), which can be 
labor intensive and require additional fees for researchers. Measuring and reporting interrater 
reliability is valuable when using more than one professional to manually score in order to assure 
concordance among raters (Hallgren, 2012).  
The researchers must describe methods used for data entry, cleaning of data, and use of 
statistical software. Data analysis methods and the statistical analysis package should be reported 
to allow for comparisons between studies. Psychometric analysis of PSM should be conducted in 
comparison to PSG, the gold standard of OSA diagnosis. Reporting correlational analyses as well 
as sensitivity, specificity, positive predictive value, and negative predictive value are necessary 
when conducting validity testing. Percentage of missing data from equipment failure, inadequate 
wear time, or participant refusal must be reported.  
 Suggestion 8. Report the PSM by model, manufacturer, and use of software. PSM 
data recording and analysis may vary between manufacturers. Selecting a PSM should be based 
on the aims and methodology of the study. It is important to report the specific PSM model, 
manufacturer, and location, as well as the software used to provide transparency of data collection 




 Suggestion 9. Provide PSM education using return demonstration methods. 
Participants need to receive in-depth training on the use of the PSM to obtain complete data. 
Researchers should have a PSM in their possession for demonstration purposes when participants 
are being enrolled into a study. The participant needs to understand how to use the PSM prior to 
enrollment. The researcher should demonstrate application of the sensors and the monitor on the 
participant so they know how the device should be worn during sleep. The researcher should 
request a return demonstration of how to apply the device and the how it is turned on and off. 
Participants should be told to feel free to ask questions about application or operation of the 
device.  
 Suggestion 10. Provide take-home PSM education materials that discuss possible 
technical difficulties and trouble-shooting techniques and research assistant contact 
information. Researchers need to be aware of technological difficulties that participants 
experience once they use the PSM at home. Many manufacturers have developed trouble-
shooting and educational handouts that need to be given to participants to take home. It is 
important to provide information on how to contact a research assistant with questions when the 
PSM is being applied. This will allow participants to contact a staff member with questions and to 
decrease amounts of missing data from insufficient wear time or incorrect application of the 
PSM.  
Conclusion 
Many methodological challenges accompany the use of PSM in research. This review 
examined published research literature of PSM use and strategies used in research. The most 
consistent strategy described in these studies was the reporting of clinical variables. The majority 
reported AHI and less commonly RDI. Data processing was reported in most manuscripts and 
many used sleep professionals to complete manual scoring. The most commonly reported 
instrumentation issue was device malfunction resulting in loss of data. Only one-third of the 
studies included participants who were not enrolled from a sleep clinic. Few studies reported 
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using patient acceptability methods. None of the research articles addressed all five 
methodological strategies developed by the authors. 
 Sampling needs to be considered when designing studies using PSM. Participants’ 
comorbid conditions should be taken into account as well their ability to complete data collection. 
Understanding the technological difficulties that can occur with PSM, such as device failure or 
problems with sensor misplacement, is needed because data inaccuracies in overnight sleep 
testing affect the analysis, reliability, and validity of the results, especially when compared to 
PSG. Researchers must determine whether data will be interpreted automatically or manually and 
will need to arrange for a qualified sleep professional to interpret findings accordingly. Finally, 
understanding the patient’s perspective of PSM is important to achieving complete data. PSM can 
be perceived as cumbersome to wear during sleep and may cause anxiety for participants if they 
are not taught and involved in interactive teaching how to use the device. 
Ten methodological strategies are suggested for adoption when using PSM in research. 
Future studies need to address the methodological challenges and adopt more consistent 
procedures and reporting using these ten suggestions to advance knowledge. The frequency of use 
of PSM in the clinical setting has increased because of the technological advancement and 
availability of the devices. Even though laboratory PSG continues to be the gold standard of OSA 
diagnosis, PSM are used for OSA screening and diagnosis in outpatient settings. The body of 
knowledge regarding PSM in research is growing rapidly but there has been no report discussing 
methodological strategies for PSM use in research outside a sleep laboratory. Awareness and 
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Methodological Strategies to use to Standardize PSM Information in Research Reports 
Sampling 
Co-morbid conditions must be taken into account when selecting inclusion/exclusion criteria. 
Instruct patient on his/her role in data collection, such as wear time and recordings on specific days of the week.  
Instrumentation Issues 
Monitors used should be at a least level III and include a minimum four channels 
Cost of PSM supplies should be considered when designing a study 
Clinical Variables 
AHI or RDI must be reported as the outcome variable from the PSM. 
Provide definition of outcome variable 
Data Processing Methods 
Researchers must determine how PSM data will be stored, analyzed, and reported when designing the study. 
Report PSM by model, use of software, and manufacturer 
Patient Acceptability  
Provide PSM education using return demonstration methods 
Provide take-home PSM education materials that discuss possible technical difficulties and trouble-shooting 
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Background: Obstructive Sleep Apnea (OSA) contributes to all-cause and cardiac mortality but 
there are no current guidelines for OSA screening in outpatient settings due to inconsistent 
measurement psychometric properties. An American Academy of Sleep Medicine task force is 
focusing on improving detection and categorization of OSA symptoms and severity to promote 
screening, assessment, and diagnosis of the disorder. The purpose of this study was to identify the 
psychometric properties of three self-report OSA screening measures (Berlin, Epworth Sleepiness 
Scale (ESS), STOP Bang) and an objective portable sleep monitor (PSM) compared to AHI 
(apnea-hypopnea index) levels (≥5, ≥ 15, and ≥ 30) from polysomnogram (PSG).  
Methods: A methodological design was used. Patients referred to a sleep specialist for an OSA 
consultation were recruited and enrolled at initial sleep evaluation. Participants completed the 
three OSA self-report screening measures and those participants who met inclusion criteria were 
sent home with a PSM for one night measurement. Automatic scoring was used. PSGs were 
ordered by the physician and AHI results were obtained from the medical record. 
Results: Participants (N=170) were enrolled (88 male, 82 female; age 54.5, SD 5.0 years). 
Almost all participants (168) completed the self-report OSA screening measures, approximately 
half (91) completed PSM measurement, and the majority (142) completed laboratory PSG. The 
STOP Bang had the highest levels of sensitivity; the ESS had the lowest. The ESS had the highest 
specificity and reliability levels; the STOP Bang had the lowest. The PSM measure had the 
highest positive predictive value (PPV) but when AHI was ≥ 30, the PPV was unacceptable. The 
PSM measure had the strongest psychometric properties of the screening measures.  
Conclusions: The STOP Bang was the preferred self-report OSA screening measure because of 
its high levels of sensitivity. A positive STOP Bang warrants assessment for OSA. The ESS is the 
least desirable screening measure. If a patient qualifies, further screening with a PSM is indicated. 
PSM measurement consistently predicted the presence of OSA but at the expense of low 
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sensitivity at AHI levels ≥ 30. PSM results can guide the referral process from primary or 



























Psychometric Properties of Obstructive Sleep Apnea Screening Measures in  
Patients Referred to a Sleep Clinic 
Introduction 
Obstructive sleep apnea (OSA) is a sleep-related breathing disorder that significantly 
contributes to all-cause (Kendzerska et al., 2014; Qaseem et al., 2014) and cardiac mortality 
(Kendzerska et al., 2014). The estimated prevalence rate of moderate to severe OSA in the United 
States is approximately 10% to 20%. The rate is thought to be influenced by the obesity epidemic 
and to have increased dramatically over the past two decades (Peppard et al., 2013).  
Repetitive obstructive breathing events are caused by increased volume in upper airway 
structures (Peppard et al., 2009) and result in intermittent hypoxia, activation of oxygen free 
radicals, and an oxidative stress response. An inflammatory process is believed to damage the 
vascular endothelium, leading to atheroma formation and vascular events (Almendros et al., 
2011; Xie et al., 2013). The long-term results of these physiological events are development of 
hypertension, tachyarrhythmias  (Bradley & Floras, 2003; Kohli et al., 2011), reduced left 
ventricular stroke volume (Yumino et al., 2013), stroke (Lipford et al., 2015), cognitive 
impairment (Aaronson et al., 2015), and insulin resistance (Heffner et al., 2012). Thus, OSA is a 
large public health burden (D. J. Gottlieb et al., 2013; Kendzerska et al., 2014).  
Despite the evidence, OSA screening measures are not used consistently in primary care 
or specialty clinics to guide the patient referral process. An American Academy of Sleep 
Medicine (AASM) task force recently released quality measures for the care of adult patients with 
OSA. The first quality measure outcome listed was to improve detection and categorization of 
OSA symptoms and severity (Aurora et al., 2015). The United States Preventative Services Task 
Force released final recommendations for OSA screening in adults; more research needs to be 
conducted in terms of OSA screening and health outcomes, the accuracy of multi-step screening 
in outpatient populations, and home based sleep testing (U.S. Preventative Services Task Force, 
2016).   
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It is clear that the United States’ health care system needs to develop a more streamlined 
approach to OSA screening, assessment, and diagnosis. The current gold standard for OSA 
diagnosis is the overnight laboratory polysomnogram (PSG) with a sleep technologist in 
attendance. Surface electrodes are applied to the patient’s body prior to falling asleep to measure 
electroencephalography, electromyography, cardiac rhythms, respiratory effort, and ocular 
movements (Marino et al., 2013). Data gathered from the laboratory PSG are analyzed by a 
physician trained in interpreting PSG results; apnea hypopnea index (AHI) levels (≥ 15) is 
diagnostic for OSA. Given the labor-intensive nature of PSG testing and the limited number of 
sleep laboratory resources, it was necessary to develop a less expensive option for OSA 
screening, assessment, and diagnosis in outpatient populations. 
The increased need for PSG services has encouraged sleep experts and monitor 
manufacturers to develop PSM that allow patients to be screened or diagnosed with OSA in home 
settings. A recent trend in OSA diagnosis includes the use of level III portable sleep monitors 
(PSM) that record oxygen saturation, heart rate, and breathing patterns (apneas, hypopneas, 
snoring, probability of Cheyne-Stokes breathing) (CleveMed & Cleveland Medical Devices Inc., 
2016). PSM that can be used for diagnostic purposes are of level III capabilities and have four 
channels. The Centers of Medicare and Medicaid have released standards in home testing. 
Reporting the AHI or respiratory distress index (RDI) after PSM is mandatory for OSA diagnosis 
for home testing (Department of Health and Human Services & Centers for Medicare & Medicaid 
Services, 2013).  
 There are no current guidelines for screening for OSA in outpatient settings; thus, 
screening is performed inconsistently. The screening measures that are often used to detect OSA 
are the Epworth Sleepiness Scale (ESS) (Johns, 1991) and the Berlin Questionnaire (Berlin) 
(Netzer et al., 1999). The STOP Bang questionnaire has been used to predict airway obstructive 
events in pre-operative patients in the acute care setting but more outpatient validation studies are 
needed (Chung et al., 2008a).  
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The knowledge gained from this study contributes to science by identifying the most 
sensitive and specific OSA measures to use in screening. Therefore, in patients who have been 
referred to a sleep specialist for a sleep disordered breathing evaluation, the purpose of this 
methodological study was to evaluate the psychometric properties of three self-report OSA 
screening measures (Berlin, Epworth Sleepiness Scale, STOP Bang) and an objective PSM 
(ApneaLink AirTM; ResMed, San Diego, CA) compared to AHI levels from PSG. 
Methods 
Research Design 
The design was a methodological study. The study was approved by the University 
Institutional Review Board. 
Sample/Setting  
 A convenience sample of adults who were being evaluated for OSA (n=173) were invited 
and (n=170) were recruited from a Midwestern sleep clinic over a five month period. The clinic 
has nine physicians specializing in pulmonary and critical care medicine; seven are board 
certified in sleep medicine and averages 20-25 new consultations for OSA a week. 
Inclusion/Exclusion Criteria 
Inclusion criteria for the study were: (a) patients ≥ 19 years old scheduled for OSA 
consultation at sleep clinic, and (b) able to communicate in writing and over the telephone in 
English.  
Patients were excluded from the study if they: (a) were using a continuous positive 
airway pressure (CPAP) device, (b) could not undergo PSG, (c) were unable to repeat back 
procedures of the research study, and (d) were pregnant.  
Exclusion criteria for collecting PSM data per AASM’s recommendations were: (a) 
persons with significant comorbid conditions such as moderate to severe pulmonary disease, 
neuromuscular disease, or congestive heart failure; or (b) suspected to have other sleep disorders 
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including central sleep apnea, periodic limb movement disorder, insomnia, parasomnia, circadian 
rhythm disorders, or narcolepsy (Collop et al., 2007).  
Conceptual Framework 
 The conceptual framework used was adapted from a framework of relationships between 
OSA and cardiovascular risk factors (Kohli et al., 2011) (Figure 1). This framework emphasizes 
the need for screening, assessment, and diagnosis of OSA, which is the main-focus of this study. 
The current practice model for screening and assessment of OSA is inconsistent. The second 
component of this framework displays the cardiovascular risk factors, consequences, and diseases 
that result from untreated OSA. Cardiovascular risk factors that were measured in this study 
include elevated heart rate, blood pressure, and decreased myocardial oxygen delivery. This 
model informs the study by emphasizing the importance of identifying measures that are highly 
predictive of OSA.  
Measurements 
Several OSA screening measures have been developed to aid health care providers in 
quickly screening patients for moderate to severe OSA in a variety of health care settings 
(Abrishami et al., 2010; Ramachandran & Josephs, 2009; Silva et al., 2011). The OSA screening 
measures selected in this study were Berlin, ESS, STOP Bang and the ApneaLink Air for 
comparisons with AHI levels from PSG. The self-report OSA screening measures were chosen 
because they are most commonly used. This section will describe these measures and present 
content regarding the validity testing used to determine the psychometric properties of the 
measures.  
Berlin. The measure (Netzer et al., 1999) was developed by primary care and pulmonary 
care physicians to predict the presence of OSA in patients. The measure has three symptom 
categories and a total of 11 items. The first category has five unique questions concerning 
frequency (rare to often) of snoring and apneas while sleeping. The second category has four 
unique questions concerning daytime sleepiness with a question about sleepiness while driving. A 
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score is positive for category 1 and 2 when a patient selects two responses from the top levels. 
The third category has two questions. A positive response indicates a patient has high blood 
pressure (>140/90 mmHg) or a BMI > 30kg/m2. The screening measure was considered negative 
if none or one of the categories were positive and positive if two or three of the categories were 
positive. The Berlin has a Flesch-Kincaid reading level of 4th grade, which is acceptable as it is 
lower than the recommended 5th grade level (Tarescavage & Ben‐Porath, 2014).  
When the measure was compared to home PSG, internal reliability testing showed 
category 1 (snoring) was high (α=0.92) but Category 2 (daytime sleepiness) was low (α=0.63). 
When the question about sleeping behind the wheel was excluded, the category 2 Cronbach alpha 
level increased (0.86) (Netzer et al., 1999). Chung et al. (2008b) and El-Sayed (2012) found the 
Berlin had higher levels of sensitivity (0.79, 0.95) than specificity (0.51, 0.07) but Netzer et al. 
(1999) reported inconsistent results (sensitivity 0.54, specificity 0.97).  
Epworth Sleepiness Scale (ESS). The measure (Johns, 1991) was developed as a simple 
questionnaire to quantify the level of daytime sleepiness in adults and is a brief, self-administered 
scale that asks the subject to rate their level of sleepiness (0= none to 3 =high chance of dozing) 
during eight daily activities. Once completed, the researcher calculates the sum of the eight 
questions and the higher the sum, the higher the sleep deficit (0-24). A score of 16 or more 
indicates a high level of daytime sleepiness (Johns, 1991) and is considered a positive screen. The 
ESS has been shown to have high internal consistency values (α=0.88) (Johns, 1992). 
Inconsistent sensitivity (0.76, 0.39) and specificity (0.48, 0.71) values have been reported (El-
Sayed, 2012; Silva et al., 2011). El-Sayed (2012) stated that the ESS has high PPV (0.91) with 
lower NPV (0.23). The ESS has a Flesch-Kincaid reading level of 8th grade, which is higher than 
the recommended 5th grade level (Tarescavage & Ben‐Porath, 2014). 
STOP Bang. The measure is comprised of eight Yes/No questions. The questions are 
arranged in the acronym of STOP Bang (snoring, tiredness, obstruction, blood pressure, BMI, 
age, neck circumference (>17 inches for male, >16 inches for female), gender (male/female). 
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With every “yes” the person scores one point for that question. The scores can range from 0 to 8, 
with greater or equal to three equating to a positive screen (Chung et al., 2008a). Higher scores 
achieved on the measure have been shown to correlate with the individual’s OSA severity (Chung 
et al., 2008b). In sleep patients, El-Sayed (2012) reported that the sensitivity of the measure 
stayed consistent between the STOP (0.95) and the STOP Bang (0.98), but Silva et al. (2011) 
reported an improvement (0.62 to 0.87). The measures PPV (0.52, 0.87) and NPV (0.9, 0.2) were 
inconsistent between studies (Chung et al., 2008a; Chung et al., 2008b; El-Sayed, 2012). The 
STOP Bang has a Flesch-Kincaid reading level of 3rd grade, which is an acceptable (Tarescavage 
& Ben‐Porath, 2014). 
ApneaLink AirTM. The ApneaLink Air (ResMed, San Diego, CA) is a level III, four 
channel, overnight PSM that is prescribed by a health care provider. The device monitors (a) 
oxygen saturation, (b) heart rate, and (c) breathing patterns (apneas, hypopneas, snoring, 
probability of Cheyne-Stokes breathing). An AHI level of ≥ 15 on the ApneaLink Air was the 
indicator of a positive screen for OSA in this study (Collop et al., 2007). Fredheim, Roislein, 
Hjelmesaeth (2014) studied an ApneaLink monitor over two nights in morbidly obese patients. 
The average sensitivity (94%) and specificity (94%) of the instrument were high at an AHI level 
≥ 15 and the night-to-night variability of the instrument was almost zero. Erman et al. (2007) 
compared the original ApneaLink monitor to laboratory PSG and reported acceptable sensitivity 
(76%) and specificity (94%) levels at AHI of ≥ 15 events per hour. Ragette, Weinreich, Teschler 
(2010) conducted a study with similar methods as Erman et al (2007), but reported higher 
sensitivity (92%) and slightly lower specificity (88%) levels. Night to night variability has been 
documented in PSM mild to moderate OSA (Prasad et al., 2016).  
Polysomnography (PSG). Laboratory PSG under supervision of a sleep technician is the 
gold standard for OSA diagnosis. Surface electrodes are applied to the patient’s body prior to 
falling asleep to measure electroencephalography, muscle activity, heart and respiratory 
physiology, and ocular movements (Marino et al., 2013). An AASM task force (2012) defined 
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apnea events in adults as “a drop in the peak signal excursion by ≥ 90% of pre-event baseline 
using an oronasal thermal senor (diagnostic study), positive assisted pressure (PAP) device flow 
(titration study), or an alternative apnea sensor, for ≥ 10 seconds” (p.606). Hypopnea events in 
adults were scored when “the peak signal excursions drop by ≥ 30% of pre-event baseline using 
nasal pressure (diagnostic study), PAP device flow (titration study), or an alternative sensor for ≥ 
10 seconds in association with either ≥ 3% arterial oxygen desaturation or an arousal (Berry et al., 
2012). The severity of OSA was defined by AASM as “an individual’s Apnea Hypopnea Index 
(AHI), which indicates how many times an hour the patient experiences obstructive events” 
(Epstein et al., 2009). AHI levels range from mild (≥ 5 and < 15), to moderate (15 ≥ and < 30), to 
severe (≥ 30) (Berry et al., 2014; Epstein et al., 2009; Guilleminault et al., 2007). The AHI levels 
are an indirect measure of myocardial oxygen delivery. Laboratory PSG data were analyzed by a 
physician trained in interpreting results. AHI levels ≥ 15 from PSG were considered positive in 
this study as it is considered to be clinically significant when treating OSA.  
Procedures 
Patients were first approached by a staff member of the clinic and asked if they were 
interested in speaking to a researcher about a study. If they agreed, patients were interviewed to 
assess their eligibility to participate in the study by the first author. After the informed consent 
process, participants completed a demographics section and three self-report OSA screening 
measures: (a) Berlin (Netzer et al., 1999), (b) ESS (Johns, 1991), and (c) STOP Bang (Chung et 
al., 2012).  
 Next, participants were taught how to use the PSM at home and were asked to enact a 
return demonstration. They were asked to wear the Level III PSM for one full night. The 
equipment for the PSM consisted of an oxygen finger probe, a nasal cannula pressure sensor, and 
a thoracic band. Participants were instructed to attach the device when they were ready to go to 
sleep, turn it on, place tape over the finger probe to secure it, and to turn it off once they woke up. 
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 After completing home sleep testing, most participants underwent PSG testing as 
prescribed by their sleep physician. PSGs were either conducted as diagnostic or split-night sleep 
studies. Some participants completed diagnostic PSG testing in their home, per insurance 
requirements. For split-night sleep studies, data were interpreted from the diagnostic portion of 
the study and not after application of OSA treatment. The PSGs were first scored by a sleep 
laboratory technician and then reviewed and dictated by a board certified sleep physician.  
Data Analysis 
Data from the self-report screening measures (Berlin, ESS, and the STOP Bang) were 
scored by the first author. There were minimal missing data on OSA screening measures. Non-
parametric statistics were used to examine clinical utility data (time to score and appropriateness 
of the measures). Data collected from the ApneaLink Air were analyzed by the ResMed 
computerized scoring program. The findings of the four OSA screening measures were compared 
to PSG. Data from PSG testing were first scored by a sleep laboratory technician and interpreted 
by a board certified sleep physician. AHI levels were divided into three severity categories; mild 
(≥ 5) moderate (≥15), and severe (≥30). In order to assess the impact of different cut-points that 
have been considered in the literature, psychometric testing for each OSA screening measure was 
completed at each AHI level (≥5, ≥ 15, and ≥ 30) for sensitivity, specificity, positive predictive 
value (PPV), and negative predictive value (NPV). Screening measures and PSG data were stored 
on a secure server. After data were collected and entered into an excel spreadsheet, data were 
cleaned and checked for outliers and missing data. Data were then analyzed using IBM SPSS 
statistical software, version 23.   
  Reliability testing was conducted using KR-20 values for the Berlin and the STOP Bang 
measures. Cronbach's alpha reliability was assessed on the Epworth Sleepiness Scale.  
Table 1 displays several types of validity testing that were used to calculate psychometric 
properties of the OSA screening measure. The types of validity testing included calculation of 
criterion validity (predictive and concurrent) and construct validity (convergent and known 
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groups testing) for each of the OSA screening measures. Predictive validity testing (sensitivity, 
specificity, positive predictive value, and negative predictive value) compared the OSA screening 
measure scores to the AHI levels from PSG. Concurrent validity testing compared a positive and 
negative screen to AHI levels from PSG. Convergent validity testing correlated each OSA 
screening measures’ score against the other measures. Known groups testing compared OSA 
measure scores in patients who did/did not have AHI ≥ 15 from PSG.  
Bivariate concurrent, convergent, and known groups validity testing were completed 
between the OSA screening measures. Independent sample t-tests were used for known-groups 
validity analysis to compare the ESS, STOP Bang, and ApneaLink Air to AHI levels ≥ 15 from 
PSG. Because the Berlin has dichotomous scoring in the third category, chi-squared testing was 
used to compare the screening measure to AHI level ≥ 15 from PSG. Phi correlations were used 
for concurrent and convergent validity analysis, to correlate positive and negative screens on 
OSA screening measures compared to each other and AHI levels from PSG. Bivariate scoring 
was used to test the validity of the measures compared to each other and using AHI ≥ 15 cut 
point. Spearman’s rho correlational analyses were conducted between the continuous scores of 
the OSA screening measures and AHI levels from PSG.  
To assess measurement agreement of AHI levels from ApneaLink Air and PSG, a Bland-
Altman plot of agreement was constructed (Bland & Altman, 1986). A single sample t-test of 
differences and regression analyses predicting differences from means were subsequently 
conducted to assess if AHI levels deviated from the null hypotheses of agreement and no 
proportional bias.  
Results 
This methodological study recruited 170 participants, 88 male and 82 female with an 
overall mean age of 54.5 (SD=15.0 years). All participants completed the Berlin Questionnaire 
and STOP Bang; almost all (n=168) completed the ESS. The majority of participants scored 
positive for OSA on the Berlin (n=143, 84%) and STOP Bang (n=149, 88%); less than one-
102 
PSYCHOMETRIC PROPERTIES 
quarter scored positive on the ESS (n=37, 22%). The Berlin Category 1, questions 2 (n=21), 3 
(n=18), and 4 (n=11) had the most amount of missing data because questions required 
information from a bed partner for a participant answer (i.e. loudness, frequency, and annoyance 
of snoring). The median score on the ESS was 10 (SD=5.4, range 1-24). The STOP Bang median 
score was 4 (SD =1.7, range 1-7). The average time to score the Berlin was 20 seconds but the 
measure was difficult for people to complete if they slept alone. The average time to complete the 
ESS was 4.6 seconds and the STOP Bang was 3.5 seconds. 
Only about half of the participants (n=91, 53%) met criteria for home sleep testing per 
AASM guidelines (Collop et al., 2007). Almost all participants who met criteria completed sleep 
testing in their homes (n=87, 96%). However, 10 (15%) of the recordings were invalid due to 
insufficient data such as wearing less than two hours (n=8) and equipment failure (n=2). The 
PSM AHI levels ranged from 0 to 139 with a mean of 21.9 (SD=27.6).  
A total of 142 (84%) participants completed physician ordered PSG; AHI levels ranged 
from 0 to 113.7 with a mean of 20.7 (SD=24.5). Slightly greater than half of the participants who 
underwent PSG testing (n=77, 54.2%) had AHI levels < 15. Therefore, AHI levels from PSG 
were positively skewed indicating an abnormal distribution, with most participants having lower 
OSA severity. Outliers (n=12) were found at high (≥ 60) AHI levels. No cases were deleted from 
the database. Less than half participants completed all OSA screening measures and PSG (n=73) 
(Table 2). 
Reliability testing was conducted on the OSA screening measures. Both the Berlin 
(KR20=0.661) and STOP Bang (KR20=0.407) measures showed low reliability but the ESS’s 
Cronbach’s alpha was high (α= 0.845).  
Table 3 displays the psychometrics of each OSA screening measure at AHI levels (≥5, ≥ 
15, and ≥ 30). For a PSG AHI cut point of ≥5 events per hour, the Berlin and STOP Bang had 
high sensitivity levels but the ESS had the highest specificity level. The ApneaLink Air had the 
highest positive predictive value (PPV) and the ESS had second highest. These levels are 
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acceptable for psychometric testing. All negative predictive values (NPV) were low and 
unacceptable for psychometric testing. 
At a PSG AHI cut point of ≥ 15 events an hour, the Berlin and the STOP Bang again had 
high sensitivity levels. The ApneaLink Air and ESS had similar acceptable specificity levels. The 
ApneaLink Air had the highest PPV and NPV and both levels were acceptable.  
At a PSG AHI cut point of ≥ 30 events an hour, the Berlin and STOP Bang repeated their 
high sensitivity levels. The ApneaLink Air and the ESS again had high specificity levels. The 
ApneaLink Air had the highest PPV. The STOP Bang had the highest NPV.  
Table 4 shows results of other validity testing, including PSG included known-groups, 
concurrent, and convergent testing. Known groups validity testing was completed with chi-square 
testing for the Berlin (χ2 3.346, p=0.067). The independent sample t-test showed there was a 
significant difference in positive (M=5.12, SD=1.61) and negative (M=4.22, SD=4.55) scores for 
the STOP Bang [t (140) = 3.40, p = .001] and a significant difference in positive (M=38.37, 
SD=30.75) and negative (M=9.0, SD=17.25) AHI levels for the ApneaLink Air [t (58.50) = 5.12, 
p = .000]. The ESS did not show a significant difference in positive and negative scores [t (138)= 
1.46, p = .146].  
 Phi-correlations were used to conduct bivariate concurrent and convergent validity 
testing. A significant but moderate correlation was detected between positive and negative AHI 
levels ≥ 15 from the ApneaLink Air and PSG (r=0.656, p=.01). A significant correlation was 
detected between positive and negative scores on the Berlin and STOP Bang (r=.375, p=.01).  
Spearman’s rho correlational analysis was completed between the continuous variables of 
the OSA screening measures and AHI levels from PSG. All OSA screening measures had a 
significant correlation to AHI from PSG (p ≤ 0.05); however, the ApneaLink Air and the STOP 
Bang had the highest correlations. ApneaLink Air AHI levels had a strong linear relationship 
(r=0.750, p=0.01) and the STOP Bang had a moderate linear relationship (r=.327, p=.01) with 
AHI levels from PSG. 
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Figure 1 shows a Bland-Altman plot analyzing the mean difference between AHI levels 
from ApneaLink Air and PSG. Clustering occurred at the lower end of mean AHI scores because 
the majority of the participants had low OSA severity. Of the mean scores, 91% (n=68) fell 
within the limits of agreement (± 2 SD) and 9% (n=7) outside of the limits of agreement. The 
single sample t-test of differences, with a test value of zero, showed no significant differences [t 
(74) = .18, p = .86]. The regression analysis showed that differences were not predictable by the 
means as the regression coefficient was non-significant (B=-.06, p = .51). These analyses show 
there was no significant difference and no proportional bias between AHI mean scores from 
ApneaLink and PSG, supporting agreement.    
 In summary, the STOP Bang had the highest sensitivity while the ESS had the lowest. 
The ESS had the highest specificity and reliability levels while the STOP Bang had the lowest. 
Some questions on the Berlin may be difficult to answer for people who sleep alone. The 
ApneaLink Air had the highest PPV. However, when the AHI was ≥ 30, the PPV was 
unacceptable. AHI levels from the ApneaLink Air and STOP Bang were most highly correlated 
with AHI levels from PSG. The ApneaLink Air had the strongest psychometric properties of all 
OSA screening measures. No difference in mean AHI levels was shown using Bland-Altman 
testing.   
Discussion 
 This study’s purpose was to identify the psychometric properties of three self-report OSA 
screening measures (Berlin, Epworth Sleepiness Scale, STOP Bang) and an objective PSM 
(ApneaLink Air) compared to AHI levels from PSG. The desired outcome was to identify the 
most reliable and valid screening measure(s) in patients referred to a sleep clinic. The major 
finding was that the ApneaLink Air most consistently predicted AHI levels indicating the 
presence of OSA. A limitation of ApneaLink Air was the low sensitivity levels at AHI ≥ 30. A 
second major finding was that none of the self-report measures had entirely acceptable 
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psychometric properties to be used independently for OSA screening. The psychometric 
properties of the STOP Bang support it as the preferred self-report screening measure.  
Regarding internal consistency reliability, the ESS had high levels but the Berlin and 
STOP Bang had low levels. Since our data were cross-sectional, stability over time was not 
measured. The stability is best supported by its ability to reproduce the same results at different 
time-periods.   
Validity testing was completed between the OSA screening measures and AHI levels 
from PSG. Concurrent validity testing showed a significant but moderate correlation between 
AHI levels from the ApneaLink Air and PSG; Bland-Altman testing showed there was no 
significant difference in mean AHI scores from ApneaLink Air and PSG. Convergent validity 
testing showed a significant but weak correlation between the Berlin and STOP Bang. The STOP 
Bang and AHI levels from the ApneaLink Air were the most proficient at determining who 
did/did not have OSA when compared to AHI ≥ 15 from PSG.    
 The ApneaLink Air had the highest level of sensitivity at AHI ≥ 5 and was the lowest at 
AHI ≥ 30. This is concerning because 40% of persons with severe OSA were not identified as 
having the sleep disorder using the device. Specificity levels were lowest at AHI ≥ 5 but were 
high at moderate and severe OSA levels; this indicates that the ApneaLink Air was not proficient 
at ruling out OSA at low levels of severity. Several other studies reported higher levels of 
sensitivity and specificity across all ranges of OSA severity than found in this study using 
ApneaLink PSM (H. Chen et al., 2009; Fredheim et al., 2014; Senchak et al., 2012). This study’s 
results may have been affected by the automatic data scoring of the PSM compared to manual 
scoring used in prior studies.   
The Berlin has been tested in different outpatient populations and has documented 
inconsistent sensitivity and specificity results compared to PSG. Some studies have found higher 
sensitivity compared to specificity level (El-Sayed, 2012) but others have reported opposite 
results (Best, Fitzpatrick, Milev, Bowie, & Jokic, 2013; Chung et al., 2008a; Geiger-Brown et al., 
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2013; Netzer et al., 1999). Both Netzer et al. (1999) and El-Sayed (2012) reported high levels of 
PPV (97%, 87%) for the questionnaire but Chung et al. (2008b) found the measure had lower 
PPV levels (51%) compared to NPV (78%). In this study, the Berlin had acceptable sensitivity 
levels but values were lower when compared to the STOP Bang. The measure produced 
unacceptable levels of specificity and inconsistent PPV and NPV. Overall, the measure performed 
inconsistently which could have been impacted by the amount of missing data from Category 1, 
questions two, three, and four.  
  The ESS has shown consistently low levels of sensitivity but higher levels of specificity 
when compared with other OSA screening measures (El-Sayed, 2012; Faria, da Costa, & Rufino, 
2015; Silva et al., 2011). This study is unique in finding an inverse relationship between PPV and 
NPV in all of the OSA screening measures when compared to mild, moderate, and severe OSA. 
This finding may have been influenced by the positive skewness of the AHI levels from PSG.  
Using a screening measure with high levels of specificity, such as the ESS, allows for accurate 
identification of patients who do not have the disease. The ESS had the highest specificity levels 
at AHI ≥ 5, which means that 13% of patients who had moderate to severe OSA at AHI levels ≥ 
15 and ≥ 30 were not identified. This leads one to ask if the strength of the specificity outweighs 
the weakness of missed OSA diagnoses.   
The STOP Bang has shown consistently high levels of sensitivity and low levels of 
specificity when compared to PSG across many psychometric studies regardless of patient 
population (Abrishami et al., 2010; Boynton, Vahabzadeh, Hammoud, Ruzicka, & Chervin, 2013; 
Chung, 2011; Chung et al., 2012; El-Sayed, 2012; Farney, Walker, Farney, Snow, & Walker, 
2011; B. Kim, Lee, Chung, Kim, & Lee, 2015; Nagappa et al., 2015; Pereira et al., 2013; Silva et 
al., 2011). The measures PPV and NPV have shown to be inconsistent between studies (Chung et 
al., 2008a; Chung et al., 2008b; El-Sayed, 2012). The high levels of sensitivity in this study can 
be explained by the scoring criteria of the measure; three positive scores indicate a positive screen 
and need for further evaluation. Using a screening measure with high sensitivity but low 
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specificity, such as the STOP Bang, can be useful when the test detects a disease that is serious 
but treatable. Therefore, the STOP Bang identified a high number of participants with the disease 
but at the cost of false positives.  
The findings from this study are most similar to those of Pereira et al. (2013). Canadian 
sleep clinic patients were studied and completed OSA screening measures (Berlin, STOP Bang, 
and Sleep Apnea Clinical Score [SACS]) and level III PSM (MediByte). The diagnostic utility of 
the tools were compared to laboratory PSG. The STOP Bang and Berlin were found to have the 
highest sensitivity levels in all severities of OSA. Although Periera et al. reported PSM findings 
as a RDI, the monitors used in both studies had very similar sensitivity levels at mild, moderate, 
and severe OSA level. This study and Periera et al (2013) reported poor probability that the PSM 
would detect an AHI ≥ 30. Collop et al. (2007) stated that false negative rates may be as high as 
17% in PSM studies. This could be influenced by scoring methods used by researchers or 
evidence of diagnostic limitations of the PSM. The calculation of total recording time rather than 
total sleep time could also affect results (Nickerson et al., 2015).  
This study has several strengths in its design. First, a sample size of N=170 was 
calculated for the sample to have sufficient number of patients both with and without OSA and to 
be representative of the general population. This assumed that approximately 24-34 participants 
out of 170 would have a negative PSG. Second, this study compared three self-report and one 
objective screening measure to PSG and variety of validity tests. This expands the knowledge of 
validity testing of the OSA screening measures and adds to the current state of the science in this 
area. Lastly, the results of this study can be generalized to other sleep clinic populations due to 
the variety of settings patients were diagnosed in (home testing and three different sleep 
laboratories).  
It is important to acknowledge the limitations of this study. The participants were 
recruited from a convenience sample at a Midwestern sleep clinic. The patients were referred 
from their primary care provider or from other health care specialties but our data did not 
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originate from a community based random sample. Another limitation of this study is the single 
night use of the ApneaLink Air and the use of automatic scoring technique. Some data were 
missing due to participant ineligibility, equipment failure, or inadequate wear time of the monitor.  
Implications for Research 
 The AASM released a call in 2016 for volunteers to serve on a new OSA Assessment 
Tools Task Force that will evaluate screening, assessment, and evaluation of current measures. 
The task force will determine if measures used currently are reliable and effective at detecting 
OSA in undiagnosed persons as well as make recommendations regarding the development of 
new tools. The development of this committee encourages researchers to conduct more validation 
testing of OSA screening measures in order to determine which tool has the best predictability 
(American Academy of Sleep Medicine, 2016).  
 There are no current guidelines for OSA screening in outpatient settings. This is due in 
part by inconsistent reports of sensitivity, specificity, PPV, and NPV of current OSA screening 
measures. Further development of screening measures needs to include studying clinical variables 
that make patients high risk for OSA (Epstein et al., 2009; Miller & Berger, 2016). Continued 
improvement in technology will assist in more accurate identification of AHI levels and reduce 
health care costs.     
Implications for Practice 
 Health care providers need increased education on the importance screening and 
assessment for OSA and encouragement to refer at-risk patients to sleep specialists for further 
evaluation. Many patients who are diagnosed with OSA have already developed hypertension, 
coronary artery disease, a stroke or have reduced left ventricular stroke volume. Early OSA 
screening and assessment may reduce the likelihood of developing these comorbid conditions. 
Screening measures are not ready to be used independently in a clinical setting. Therefore, 
clinicians need to integrate assessment for OSA risk factors into their practice, such as evaluation 
of patient’s comorbid cardiovascular and respiratory conditions, BMI, conducting a Mallampati 
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score, and measuring a neck circumference. In addition, evaluating daytime sleepiness and 
functioning levels are clinically relevant (Epstein et al., 2009; Miller & Berger, 2016).   
  To help guide the referral process to sleep specialists, sleep screening and assessment 
can be followed by the use of a PSM. As evidenced in this study, PSM have been shown to be 
effective in both screening and diagnosing OSA in specific patient populations. However, only 
53% of participants qualified for PSM per AASM guidelines because of comorbid conditions 
(Collop et al., 2007). Patients who are at risk for OSA need to be identified early in their disease 
trajectory, prior to development of cardiovascular disease. The use of PSM can assist clinicians in 
deciding which patients need to be referred to sleep specialists for OSA diagnosis. Patients who 
have AHI levels from PSM ≥ 5 and < 15 need an assessment of daytime sleepiness. If patients 
report excessive daytime sleepiness, a referral to a sleep specialist is necessary. Sleep specialists 
are trained to manually interpret PSM data and can determine if results are accurate for OSA 
diagnosis or if laboratory sleep testing is needed.  
 In conclusion, this study demonstrated that the STOP Bang questionnaire was the 
preferred self-report OSA screening measure as it had the highest level of sensitivity. The ESS 
was found to be the least psychometrically desirable. A positive screen on the STOP Bang 
warrants assessment for OSA. If a patient qualifies, further screening with a PSM is indicated. 
The ApneaLink Air had the most consistent ability to predict the presence of OSA but at the 
expense of low sensitivity levels at AHI ≥ 30, indicating some patients with severe OSA would 
have a missed diagnosis. PSM need to be used to guide the referral process from primary or 
specialty care to sleep specialist. Earlier screening and detection of OSA will reduce the 
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Figure 1: Conceptual Framework of the Relationship between Obstructive Sleep Apnea and 









































Predictive The degree to which the OSA screening measures predict PSG AHI levels ≥ 15 (sensitivity, 
specificity, positive predictive value, negative predictive value).  
Concurrent Correlating +/- screens on OSA measures scores to the AHI levels from laboratory PSG.  
Construct Validity 
Convergent Correlating each measure’s +/- scores against the other OSA screening measures.  























Table 2  


















































Measure   
STOP Bang 
(N=170)   
ApneaLink 
(n=83) 
Cut-point 5 15 30 5 15 30 
Sensitivity 94.44% 95.38% 96.77% 81.97% 78.95% 60.00% 
Specificity 20.59% 12.99% 10.81% 57.14% 86.49% 87.27% 
PPV 79.07% 48.06% 23.26% 89.29% 85.71% 63.16% 
NPV 53.85% 76.92% 92.31% 42.11% 80.00% 85.71% 
 
Berlin Questionnaire (Berlin); Epworth Sleepiness Scale (ESS); negative predictive value (NPV); positive predictive 
value (PPV)  
 
Measure   
Berlin 
(N=170)     
ESS 
(n=168)   
Cut-point 5 15 30 5 15 30 
Sensitivity 88.89% 92.31% 90.32% 17.92% 20.63% 31.03% 
Specificity 20.59% 18.18% 14.41% 88.24% 87.01% 87.39% 
PPV 78.05% 48.78% 22.76% 82.61% 56.52% 39.13% 




Known Groups, Concurrenta ,and Convergentb Validity Testing of OSA Screening Measures Compared to AHI Levels ≥ 15 (PSG) 
 Berlinb  
(n=170) 




















Epworth  -.022   -.121 -.060 .103 
STOP Bang  .375**  -.121  .196 .145 
ApneaLink Air  .196  -.060 .196  .656** 




 (χ2 3.346,  
p=0.067)c 
  
[t(138) = 1.46,  
p = .146]d 
 
 [t(140) = 3.40 ,  
p = .001]d 
  
[t(58.45) =5.12, 
p = <.001]d 
 
Berlin Questionnaire (Berlin); Epworth Sleepiness Scale (ESS); polysomnogram (PSG) 
** Correlation is significant at the 0.01 level (2-tailed). 
a. Concurrent validity 
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Chapter IV.B. Analysis of Demographic, Clinical, and Biomarker Characteristics to 
Determine Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern 
Sleep Clinic Patients 
Dissertation Aim #2 
The second aim for this dissertation study was to examine if selected demographic (age, 
gender), clinical (diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, 
lung disease, smoking history, alcohol intake), and biomarker (blood pressure, heart rate, body 
mass index (BMI), neck circumference, Mallampati score) variables predicted apnea hypopnea 
index (AHI) from polysomnography (PSG).  
 Methods  
Research Design 
The design is a descriptive, prospective, cross-sectional study. The study was approved 
by the University Institutional Review Board. 
Sample/Setting  
 A convenience sample of adults (n=173) were invited and (n=170) were recruited. All 
patients were being evaluated for obstructive sleep apnea (OSA) were recruited from a 
Midwestern sleep clinic.  
Chapter IV. A. Methods 
Please see Chapter IV.A. for inclusion/exclusion criteria, informed consent, and 
procedures.  
Data Analysis 
An estimate of 15-20% of PSG results are negative at Nebraska Pulmonary Specialties, 
LLC for patients who undergo testing. A power analysis determined that a sample size of N=170 
was a sufficient number of patients both with and without OSA and to be representative of the 
population. This calculation assumed that approximately 24-34 participants out of 170 would 
have a negative PSG result. For the regression analysis, n= 130 participants were included in the 
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model. A maximum of 15 variables could have been included in the model if all correlated with 
the outcome variable at p<.20. There were 15 demographic, clinical, and biomarker 
characteristics. Therefore, a multiple regression model with 15 predictors and 130 participants 
would provide 80% power to detect an effect size of f2 = .15, which is a medium effect size. The 
planned sample size provided sufficient power to detect the effects of interest for this analysis.   
First, data were entered into a secured Excel spreadsheet and rigorous procedures were 
followed for data entry and editing. Data were cleaned and checked for outliers and missing data; 
no outliers were removed. Descriptive statistics were performed on the sample of participants. 
Next, Spearman’s correlational analyses were conducted; demographic (age, gender), clinical 
(diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, lung disease, 
smoking history, alcohol history), and biomarker (blood pressure, heart rate, body mass index, 
neck circumference, Mallampati score) variables were compared to determine their relationship 
with AHI levels from PSG. Then, assumptions of multiple regression analysis (linearity, 
homoscedasity, normality, and multicollinearity) were assessed. Bivariate scatterplots were used 
to assess linearity and homoscedasity. Normality was evaluated by a) histograms to assess normal 
distributions and b) skewness and kurtosis values. Skewness was assessed by examining the 
symmetry of the distribution (positive or negative). The outcome variable was positively skewed, 
indicating an abnormal distribution of data, and a log transformation of AHI levels (PSG) was 
performed. Transformation of the AHI level scores (PSG) reduced the impact of the outliers. The 
transformation of the variables normalized distribution of the AHI levels (PSG).  
Potential covariates associated with AHI levels from PSG were examined for inclusion in 
the multiple regression model. Prior to entering the variables into the model, correlational 
analyses also were conducted between the predictors. Multiple regression analyses were used to 
test a model of predictors of log AHI levels from PSG in participants (gender, comorbid health 
conditions, smoking history, current tobacco use, alcohol use/amount, systolic and diastolic blood 
pressure, heart rate, body mass index, neck circumference, and Mallampati score). Baseline 
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variables that correlated with log AHI levels from PSG, at a significance level of P<.20, were 
included in the model following a model-building strategy outlined by Hosmer and Lemeshow 
(Hosmer & Lemeshow, 2000).  
Variables that met the Homser and Lemeshow (2000) criteria and that were not highly 
inter-correlated were entered into the multiple regression model. Using the model respecification 
technique, age, diabetes mellitus, coronary artery disease, heart attack, stroke, current or past 
tobacco use, alcohol use, diastolic blood pressure, heart rate, and Mallampati score were deleted 
from the model (p > .05). Interactions between variables were then tested.  
 Descriptive statistics and multiple regression analysis were performed using IBM SPSS 
Statistical Software, Version 23.  
Results 
This cross-sectional descriptive study took place in a sleep clinic and recruited patients 
who were referred for sleep evaluation (n=170). The sample consisted of approximately half 
males and half females. The means and standard deviations of clinical predictors were analyzed 
(Table 1). On average, the participants were middle aged, obese, and pre-hypertensive. The 
majority of patients reported using alcohol at least once a week. The most commonly self-
reported co-morbid conditions were hyperlipidemia, lung disease and diabetes mellitus type II 
(Table 2).  
Multi-collinearity was assessed for and confounding factors, correlations, and potential 
interactions were explored. Systolic and diastolic blood pressures were highly correlated with 
each other (ρ=0.464). Diastolic blood pressure was deleted from the model because it had a 
multicollinearity effect with systolic blood pressure. A slightly higher correlation was found 
between systolic blood pressure and AHI levels from PSG (Table 3). Interactions were tested 
between diastolic blood pressure and other variables and one was found with lung disease (Figure 
1). If participants had lung disease, diastolic blood pressure did not predict OSA; however; if lung 
disease was not present, diastolic blood pressure had a positive relationship with PSG. The 
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Spearman’s correlation between diastolic blood pressure and PSG was not significant for those 
with lung disease (ρ =-.071, p=.788, N=17) but for those without lung disease, there was a 
significant correlation (ρ =.32, p=.001, N=113). 
Interactions in the model were tested between gender and other variables (high 
cholesterol, BMI, neck circumference, systolic blood pressure) (Table 4) and between systolic 
blood pressure and other variables (high cholesterol, BMI, neck circumference, and lung disease) 
(Table 5). In Table 4, there was a significant amount of variance accounted for by the variables in 
the model (F=3.07, p=.002, adjusted R2=.138, R2=.205) with 20.5% of the variability of the 
response variable accounted for by the predictors. Table 5 also supports a significant amount of 
variance accounted for by variables in the model (F=2.89, p=.003, adjusted R2=.128, R2=.196). 
No interactions occurred between gender or systolic blood pressure and other variables, meaning 
that the effects of the variables on AHI levels from PSG did not vary depending on gender or 
systolic pressure.  
Of the 130 participants in the final regression model, 69 (53.1%) had an AHI < 15 and 61 
(46.9%) had an AHI ≥15. The final model (Table 6) included gender, high cholesterol, lung 
disease, systolic blood pressure, body mass index, and neck circumference (n=130); the model 
predicted a significant level of variance in the continuous AHI levels by the variables in the 
model (F =4.57, p<.001, R2=0.183, adjusted R2=0.143). The significant predictors in the model 
included lung disease, systolic blood pressure, and body mass index. Systolic blood pressure and 
BMI independently predicted AHI levels from PSG. Lung disease was a negative predicator for 
AHI levels from PSG; therefore, persons with lung disease were less likely to have elevated AHI 
levels from PSG. 
Discussion 
This study found that participants BMI, systolic blood pressure, and lack of lung disease 
diagnosis were predictors for AHI levels ≥ 15 from PSG. The demographic, clinical, and 
biomarker variables that did not predict AHI levels from PSG were age, gender, diabetes, 
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coronary artery disease, hyperlipidemia, myocardial infarction, stroke, smoking history, alcohol 
intake, diastolic blood pressure, heart rate, neck circumference, and Mallampati Score. To our 
knowledge, this is the first study to compare this combination of variables to AHI levels from 
PSG. 
BMI was shown to be a significant predictor for OSA and the relationship has previously 
been studied. Rogers et al. (2015) investigated OSA predictors among African American 
participants with metabolic syndrome (n=1,035). African American participants were at greater 
risk for OSA relative to other adults in developed countries; obesity was found to be the strongest 
independent predictor for OSA (OR=1.59, p <.001). Natsios et al.(2015) performed a 
retrospective cohort study using a university database (N=1501) to determine predictors of 
laboratory diagnosis of OSA for development of hypertension. BMI was found to be an accurate 
predictor of hypertension in patients with OSA (p<.001). Kendzerska et al. (2014) conducted a 
systematic review of the prognostic value of clinical and PSG characteristics of OSA for adverse 
long-term outcomes of untreated OSA in adult patients. OSA was found to be associated with all-
cause and adverse cardiac outcomes (15 of 26 studies), including BMI (3 of 21 studies) and 
hypertension (5 of 21 studies). 
Systolic blood pressure was shown to be a significant predictor of OSA. Other studies 
have confirmed the relationship between these two health conditions. Pedrosa et al. (2011) 
conducted a cross-sectional study (N=125) that found OSA was the most common condition 
(64%) associated with resistant hypertension. Pedrosa et al. (2013), studied the effect on blood 
pressure with the use of continuous positive airway pressure (CPAP) to treat OSA in patients with 
resistant hypertension (N=243). Findings were that the treatment of OSA with CPAP significantly 
reduced daytime systolic blood pressure levels (p<.05). Haas et al.(2005) studied the association 
between systolic and diastolic hypertension in relation to OSA. Findings supported that OSA was 
associated with systolic and diastolic hypertension (AHI 15 to 29.9, OR=2.38; AHI ≥30, 
OR=2.24) in participants less than 60 years old.  
130 
 
  The finding that the absence of lung disease was a significant predictor for OSA was 
unique to this study. Most studies report a positive relationship between the presence of lung 
disease and OSA. Zidan, Dabbis, and Gharraf (2015) assessed the prevalence of OSA in a group 
of asthmatics (n=30) and controls (n=12). A regression analysis revealed that higher BMI 
(p=0.03), gastroesophageal reflux disease (p=.034), and asthma severity (FEV1%) (p<.001) were 
significant independent predictors for the development of OSA. Furthermore, the presence of 
OSA was significantly associated with worse asthma control (p<.001). In a similar experimental 
study, Greenberg-Dotan et. al. (2014) aimed to determine whether there is increased prevalence 
of obstructive lung diseases in patients with OSA (N=1,497) when compared to a control group 
(n=1,489). The study found that chronic obstructive pulmonary disease (COPD) (p<0.0001), 
asthma (p<0.0001), and COPD with asthma (p<0.0001) were more prevalent in patients with 
OSA across all AHI severities, compared to controls. One reason this study’s results differ from 
prior studies may due to the small sample of participants recruited with lung disease (n=17).  
Interpretation of the final model deserves further discussion due to its unique findings. In 
Table 6, the F-test was highly significant, thus we can assume that there is a relationship between 
the variables in the model and the outcome variable. R2, also known as the coefficient of multiple 
determination, is a statistical measure of how close the data are to the fitted regression line and 
provides an estimate of strength of the relationship between the model and the response variable 
(Pagano, Gauvreau, & Pagano, 2000). In Table 6, R2= .183 and adjusted R2=.143, therefore 
18.3% of variability of the response variable was accounted for by the predictors; however, the 
model was overall significant which shows that BMI, systolic blood pressure, and absence of lung 
disease are still associated with log AHI levels from PSG. This model can be subjectively 
considered significant because it is reasonable to assume that an individual’s BMI, systolic blood 
pressure, and absence of lung disease can be affected by many other health conditions besides 
OSA; however, because the model was shown to be significant, the relationship between the 
comorbid conditions and OSA deserves further investigation.    
131 
 
This study had several strengths. All participants (N=170) completed the demographics 
and health history questionnaire. Participants were given adequate time and support to complete 
demographic questionnaires in private and were given adequate chances to ask questions. Also, 
the sample consisted of persons with chronic comorbid conditions.  
A limitation of the study was that lung disease was measured via self-report from 
participants and was not validated using health records; this applies to all comorbid health 
conditions and demographic variables obtained. Also, chronic disease severity was not assessed, 
measured, or recorded. Only subjects who completed demographic, clinical, and biomarker 
variables, and had AHI levels from PSG were included in the model (N=130). 
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Figure 1: PSG AHI Diastolic Blood Pressure and Lung Disease Interaction  
 




















Mean and Standard Deviation of Participants’ (N=170) Clinical Health 
Predictors 
Clinical predictors Mean ± SD Range 
Gender (88M, 82F) NA 
Age 54.5 ± 15 years 20.4-89.5 
Body mass index 34.8 ± 7.6 kg/m2 20.2-65.1 
Mallampati score 2.7 ± 1.1 1-4 
neck circumference 16 ± 2.1 inches 12-23.5 
heart rate 93 ± 18.4 41-137 
systolic blood pressure 124 ± 15 94-190 
diastolic blood pressure 73± 10 32-99 
BMI: 18.5, Underweight; 18.5-24.9, Healthy weight; 25.0-29.9, Overweight; 30.0 or > Obese  
Blood systolic blood pressure (mmHg): < 120, normal; 120-139, prehypertension; 140-159, stage 1 




















Number of Participants’ Co-morbid Conditions (n=170) 
Co-morbid conditions N 
Lung disease 25 
Diabetes mellitus 25 
Coronary artery disease 16 
High cholesterol 71 
Heart attack 12 
Hypertension 80 
Stroke 5 
Current tobacco use 17 
Current alcohol use 115 





















Correlational analyses between clinical variables and AHI levels from PSG (n=96-142) 
  
AHI levels per Polysomnography 
Correlation 
Coefficient                  Sig. (2-tailed) N 
  Age .065 .443 142 
Gender (0-male, 1-female) -.210* .012 142 
Diabetes mellitus -.040 .635 142 
Coronary artery disease -.014 .870 142 
High cholesterol .110 .194 142 
Heart attack .065 .439 142 
Stroke -.052 .539 142 
Lung disease -.132 .132 132 
Current tobacco use -.001 .989 142 
Previous smoking history .055 .532 132 
Current or Previous Smoker .007 .935 142 
Alcohol use .078 .354 142 
Amount of alcohol use .051 .623 96 
Systolic Blood Pressure .256** .002 140 
Diastolic blood pressure .232** .006 140 
Heart rate .056 .514 140 
BMI .173* .041 140 
Neck circumference .302** .000 141 
Mallampati Score -.029 .740 132 
*. Correlation is significant at the 0.05 level (2-tailed). 







 Interactions Tested Between Gender and High Cholesterol, BMI, Neck Circumference, 
and Systolic Blood Pressure (n=130) 
 




F p Partial Eta Squared 
Corrected Model 32.844 10 3.284 3.068 .002 .205 
Intercept .276 1 .276 .258 .613 .002 
Gender .355 1 .355 .332 .566 .003 
High cholesterol 1.341 1 1.341 1.253 .265 .010 
Lung disease 5.797 1 5.797 5.416 .022 .044 
Systolic blood pressure 2.123 1 2.123 1.984 .162 .016 
Body mass index 7.612 1 7.612 7.112 .009 .056 
Neck circumference 1.325 1 1.325 1.238 .268 .010 
Gender*High 
Cholesterol 
.390 1 .390 .365 .547 .003 
Gender*Body Mass 
Index 
3.113 1 3.113 2.908 .091 .024 
Gender*Neck 
Circumference 
1.549 1 1.549 1.447 .231 .012 
Gender*Systolic Blood 
Pressure 
.138 1 .138 .129 .720 .001 









Interactions Tested Between Systolic Blood Pressure and High Cholesterol, BMI, Neck 
Circumference, and Lung disease (n=130) 
 




F p Partial Eta 
Squared 
Corrected Model 31.344 10 3.134 2.894 .003 .196 
Intercept .535 1 .535 .494 .483 .004 
Gender 3.388 1 3.388 3.128 .080 .026 
High cholesterol .008 1 .008 .007 .933 .000 
Lung disease .351 1 .351 .324 .570 .003 
Systolic blood pressure .200 1 .200 .185 .668 .002 
Body mass index .294 1 .294 .271 .603 .002 
Neck circumference .948 1 .948 .876 .351 .007 
High Cholesterol* Systolic 
Blood Pressure 
.035 1 .035 .032 .858 .000 
Systolic Blood Pressure * 
Body Mass Index 
.063 1 .063 .058 .810 .000 
Systolic Blood Pressure* 
Neck circumference 
.974 1 .974 .899 .345 .007 
Lung disease*  
Systolic blood pressure 
.937 1 .937 .865 .354 .007 








Final Model of Multiple Regression with Respecification Analysis for 
Variables Predicting Continuous AHI Levels from PSG (n=130) 
 b SE (b) Β t p 
Gender -.491 .269 -.220 -1.826 .070 
Body mass index .040 .019 .245 2.162 .033* 
Systolic blood 
pressure 
.013 .006 .187 2.107 .037* 
Neck circumference -.005 .070 -.009 -.068 .946 
Lung disease -.662 .275 -.201 -2.406 .018* 
High cholesterol .164 .185 .073 .886 .377 
 
R2 = .183, adjusted R2=.143, F = 4.579, p <.001 
a. Dependent Variable: Log (PSG) 
b. Gender: male, 0; female, 1 


















Chapter V: Conclusions, Discussion, and Implications for Research and Practice 
 This dissertation study was developed from the progression of knowledge focusing on the 
current state of screening, assessment, and diagnosis of obstructive sleep apnea (OSA). Three 
manuscripts included in this document are the result of the learning process that occurred 
throughout the PhD program with the dissertation serving as the culmination of the doctoral 
processes. The following paragraphs are a summary of knowledge development presented in 
Chapters 1-4.B. followed by implications for future research, application to clinical practice, and 
the author’s next steps in scholarship.  
Chapter I: Introduction 
 Chapter 1 provided an introduction to the background and significance of the dissertation 
study. The theoretical background and conceptual framework for the study were provided. 
Definitions for major concepts (obstructive sleep apnea (OSA), screening, assessment, diagnosis) 
were discussed. A discussion of reliability and validity was provided. The most commonly used 
OSA screening measures (the Berlin Questionnaire (Berlin), Epworth Sleepiness Scale (ESS), 
and the STOP Bang) were addressed in terms of types of questions, scoring, and limitations of the 
tools. The description of OSA assessment and diagnosis was discussed. Lastly, an introduction to 
the dissertation documents was presented.  
Chapter II: Screening and Assessment for OSA in Primary Care 
 Sleep disorders are common in primary care patients but are rarely self-reported and go 
unaddressed by primary health providers. This state of the science publication is an integrative 
review aimed at evaluating current evidence regarding the screening and assessment for 
obstructive sleep apnea (OSA) in primary care settings. This publication also includes a 
discussion of OSA screening measures and the published psychometric properties of each one. 
This is the first publication to discuss the current state of the science of screening and assessment 
for OSA in primary care (Miller & Berger, 2016).   
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Specific journal articles that were included in the literature review were based on the 
following criteria: (a) published in the English language; (b) participants studied in primary care 
setting/internal medicine; (c) providers practicing in primary care/internal medicine; (d) included 
an OSA screening process; (e) compared OSA screening tools; and (f) used OSA assessment 
criteria. Studies were excluded if: (a) conducted in any setting other than primary care/internal 
medicine; (b) focused on sleep disorders other than OSA; (c) discussed long-term management of 
OSA in primary care settings; (d) focused on management of OSA patients by sleep physicians; 
and (e) used pediatric participants. After implementing the exclusion criteria, 17 articles met 
criteria for this integrative literature review. 
 OSA screening measures were developed to aid health providers in quickly screening for 
OSA in variety of health care settings (Abrishami et al., 2010; Ramachandran & Josephs, 2009; 
Silva et al., 2011). As previously discussed, self-report screening measures are intended to 
identify the patients that are in need of further assessment and possible referral to sleep 
specialists. The screening measures with extensive validation studies that were discussed in the 
review were the Berlin Questionnaire (Netzer et al., 1999), the Epworth Sleepiness Scale (ESS) 
(Johns, 1991), and STOP Bang (Chung et al., 2008a). 
  Studies that met the inclusion criteria were 14 non-experimental and three experimental 
designs. The results of the integrative literature review support that OSA is associated with 
exacerbation of comorbid conditions and increased risk for morbidity and mortality. 
Methodological testing of the OSA screening measures is necessary in primary care. There is lack 
of consensus in the role that  primary care providers can perform in screening, assessing, and 
referring patients to sleep specialists for OSA. The findings from the review confirm that the 
current practice model of screening and assessment for OSA in primary care is fragmented and 
ineffective.   
Chapter III: Methodological Strategies in Using Portable Sleep Monitoring in Research 
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OSA in adults has been increasing in prevalence over the last two decades, which is 
attributed in part to the obesity epidemic (Kendzerska et al., 2014; Peppard et al., 2013; Qaseem 
et al., 2014). Because of the increase in OSA prevalence, sleep laboratory and diagnostic 
polysomnogram (PSG) services are in high demand. Use of portable sleep monitors (PSM) has 
increased in popularity due to technological improvements and accessibility. American Academy 
of Sleep Medicine (AASM) established clinical guidelines that state the diagnosis of OSA needs 
to occur with a comprehensive sleep evaluation and with Level III monitors with at least four 
channels (Collop et al., 2007). PSM allow patients and clinicians a less expensive diagnostic 
option for OSA in outpatient and home settings with satisfactory positive predicative value (PPV) 
when compared to PSG  
There are two purposes of the focused review on the methodological strategies when 
using PSM in research. The first purpose was to synthesize the literature on use of level III PSM 
in adult patients, in terms of: (a) sampling; (b) instrumentation issues; (c) clinical variables; (d) 
data processing; and (e) patient acceptability. The second purpose was to identify methodological 
strategies to use to standardize PSM information in research reports. This is the first known 
focused review that presents suggestions for adoption when using PSM in research. Articles were 
retrieved from 2000 to 2016 (n=371). Most articles were excluded (n=337) because Level III 
PSM were not used. After implementing inclusion/exclusion criteria, 33 articles were included in 
the focused review.  
The research articles were inconsistent in reporting strategies. The authors identified five 
criteria to examine. Samples of most studies included sleep participants who had OSA or were 
suspected of having OSA (n=20). The most commonly reported instrumentation issue was device 
malfunction. Scoring practices of the PSM data were discussed in the majority of the articles 
(n=19). Almost all studies reported clinical variables (n=30). Several different PSM (n=14) were 
used. Few studies (n=6) reported information on patient acceptability.  
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Ten suggestions were made for adoption when using PSM in research. The body of 
knowledge regarding PSM in research is growing rapidly. Future studies need to address the 
methodological challenges and adopt the ten suggestions to promote consistency of reports and 
advance knowledge. 
Chapter IV.A.: Psychometric Properties of OSA Screening Measures in Patient Referred to 
a Sleep Clinic; Aim 1 of Dissertation Study 
 Repetitive obstructive breathing events are caused by increased volume in upper airway 
structures (Peppard et al., 2009) and result in intermittent hypoxia, activation of oxygen free 
radicals, and an oxidative stress response. The long-term effects are development of co-morbid 
vascular comorbid conditions (Aaronson et al., 2015; Heffner et al., 2012; Kohli et al., 2011; 
Lipford et al., 2015; Yumino et al., 2013). Despite the evidence, OSA screening measures are not 
used consistently in primary care or specialty clinics to guide the patient referral process. 
An AASM task force is focusing on improving detection and categorization of OSA 
symptoms and severity to promote screening, assessment, and diagnosis of the disorder (Aurora 
et al., 2015). More psychometric testing of OSA screening measures was needed to determine 
how well they predicted OSA in outpatient populations. The purpose of this methodological study 
was evaluate the psychometric properties of three self-report OSA screening measures (Berlin, 
ESS, STOP Bang) and an objective PSM (ApneaLink Air) compared to AHI levels (≥5, ≥ 15, and 
≥ 30) from PSG in patients referred to a sleep clinic. 
Patients referred to a sleep clinic (n=170) were enrolled in this study. The majority 
completed all self-report screening measures (n=168). Only about half met criteria for home sleep 
testing per AASM guidelines (n=91), however some were invalid due to insufficient data (n=8) 
and equipment failure (n=2). Most participants completed physician ordered PSG testing (n=142). 
The number of participants with complete data was 73. 
Reliability testing was completed on the self-report screening measures. The ESS had 
high Cronbach’s alpha levels, however, the Berlin and STOP Bang had very low Kudar-
145 
 
Richardson (KR-20) levels. Validity testing was completed between the OSA screening measures 
and AHI levels from PSG. The STOP Bang and ApneaLink Air AHI levels were best at 
predicting participants who did/did not have OSA compared to AHI ≥ 15 from PSG.  
Findings were that the STOP Bang had the highest sensitivity of the self-report measures 
while the ESS had the lowest; however, the ESS had the highest specificity. The Berlin produced 
the second highest sensitivity levels. The ApneaLink Air AHI levels had the highest PPV. It is 
important to note that not one self-report OSA screening measure has the psychometric properties 
to be implemented on a standardized basis. However, sleep screening and assessment can be 
followed by the use of a PSM; patients can then be referred to a sleep specialists when indicated. 
Chapter IV.B.: Analysis of Demographic, Clinical, and Biomarker Characteristics to 
Determine Predictors of Apnea Hypopnea Index from Polysomnography in Midwestern 
Sleep Clinic Patients 
 This manuscript focuses on Aim 2, to examine if selected demographic (age, gender), 
clinical (diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, lung 
disease, smoking history, alcohol intake), and biomarker (blood pressure, heart rate, body mass 
index (BMI), neck circumference, Mallampati score) variables predicted apnea hypopnea index 
(AHI) from PSG. To our knowledge, this is the first study to compare these combinations of 
variables to AHI levels from PSG. 
 The sample (N=170) consisted of approximately half males and half females. The 
majority of the participants consumed alcohol, had pre-hypertension, and hyperlipidemia.  
Multi-collinearity was assessed and confounding factors, correlations, and potential 
interactions were explored. Systolic and diastolic blood pressures were highly correlated with 
each other therefore diastolic blood pressure was deleted from the model because it had a 
multicollinearity effect. Interactions in the model were tested between gender and other variables 
(high cholesterol, BMI, neck circumference, systolic blood pressure) and between systolic blood 
pressure and other variables (high cholesterol, BMI, neck circumference, and lung disease). No 
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interactions occurred between gender or systolic blood pressure and other variables, meaning that 
the effects of the variables on AHI levels from PSG did not vary depending on gender or systolic 
pressure. Participants who completed the pertinent demographic, clinical, and biomarker 
variables, and had AHI levels from PSG, were included in the model (N=130).  
The final model included gender, high cholesterol, lung disease, systolic blood pressure, 
BMI, and neck circumference. The entire model predicted a significant level of variance in the 
outcome by the variables in the model (F =4.573, p<.001, R2=.183, adjusted R2=.143). This study 
found that participants BMI, systolic blood pressure, and lack of lung disease diagnosis were 
independent predictors for AHI levels from PSG. Systolic blood pressure and BMI independently 
predicted AHI levels from PSG. Lung disease was a negative predicator for AHI levels from 
PSG; therefore, persons with lung disease were less likely to have OSA.  
A strength of this study was that all participants completed the demographics and health 
history questionnaire. A limitation of the study was that lung disease was measured via self-report 
from participants and was not validated against health records; this applies to all comorbid health 
conditions and demographic variables obtained.  
Implications for Research 
An AASM task force recently released quality measures for the care of adult patients 
with OSA as well to improve detection and categorization of OSA symptoms and severity 
(Aurora et al., 2015). AASM then released a call for volunteers to serve on a new OSA 
Assessment Tools Task Force that will evaluate screening, assessment, and evaluation of current 
measures. The task force will determine if measures used currently are reliable and effective at 
detecting OSA in undiagnosed persons. The goals of this task force are three fold: (a) evaluate 
current OSA screening measures pre and post continuous positive airway pressure titration to see 
if they are reliable and effective, (b) develop a resource to inform members of existing measures, 
and (c) recommend whether the AASM needs to develop additional screening measures and 
mechanisms for completing this task (American Academy of Sleep Medicine, 2016). The 
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development of this committee emphasizes the need for researchers to collaborate and conduct 
validation testing of OSA screening measures. One timely implication is to submit a rigorous 
manuscript to a high impact journal describing results of Aim 1 (Chapter IV.A.). A second timely 
implication is to contact AASM task force members to express interest in future collaborations 
that address these three goals.  
Further research is needed to determine the psychometric properties of the STOP Bang 
and appropriate use of PSM in outpatient settings. The findings from this study support further 
research of the STOP Bang in primary care and specialty settings because its ability to be quickly 
scored, acceptable reading level, and high levels of sensitivity. However, the STOP Bang has 
shown high false positive rates for OSA. The use of Level III PSM has been studied primarily in 
sleep laboratory settings and needs more validation testing in outpatient settings 
Potential future studies will now be presented that are appropriate for this author’s career 
stage. The first study is planned as a sub analysis using data collected from for this dissertation 
study. Because the STOP Bang was shown to have high false positive rates with a score ≥ 3, the 
analysis would compare a score ≥ 5 to Level III PSM apnea hypopnea index (AHI), respiratory 
distress index (RDI), and oxygen desaturation index (ODI). These measures would then be 
psychometrically compared to PSG AHI, RDI, and ODI data to further test predicative, 
convergent, and concurrent validity. The results from the secondary analysis would test higher 
STOP Bang cut-off scores against data from PSM and PSG testing in hopes to improve the 
psychometrics of the measure.  
To build on results of the sub analysis, a pilot study will take place in a primary care 
and/or specialty setting. Patients with hypertension, BMI ≥ 35, and/or atrial fibrillation will be 
screened for study eligibility that includes meeting AASM criteria for PSM testing. After 
participant enrollment, a chart review will be completed to track co-morbid conditions, 
medications, and vital signs. The clinic nurse will interview and gather data to complete and score 
the STOP Bang and ESS, to assess for daytime sleepiness. Although the ESS has proven to be 
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psychometrically inadequate for OSA screening, it is still a valuable measure for daytime 
sleepiness. Participants will then complete two-nights of home PSM testing. STOP Bang scores ≥ 
5 and ESS total scores will be compared to AHI, RDI, and ODI from manually scored PSM data. 
Providers would be made aware of participants’ STOP Bang, ESS, and PSM scores after testing 
were completed.  
Participants who were referred to sleep specialists will be followed through completion of 
PSG. Data from STOP Bang ≥ 5, ESS, and manually scored PSM will be psychometrically 
compared to physician ordered PSG results (AHI, RDI, ODI). A chart review will be conducted 
on all participants who were not referred to a sleep specialist. The research team will conduct a 
six-month follow-up to collect data on OSA diagnosis, treatment, health status and vital signs. 
The longitudinal design of this study will allow researchers to follow patients who are at high-risk 
for OSA through his/her treatment plan, initiated in a primary care or specialty setting. This pilot 
study would be the first to test the OSA screening measures in this manner. 
Implications for Practice 
 Screening and assessment for OSA needs to become a priority in primary care and 
specialty settings. Health care providers need education on the importance of early screening, 
assessment, and diagnosis of OSA and how early detection may reduce the development of co 
morbid conditions (Bailes et al., 2009; Collop & Shafazand, 2013). In this study, BMI, systolic 
blood pressure, and absence of lung disease were predictors of OSA. The first two co-morbid 
conditions are in congruence with other studies. Many of the participants had chronic cardiac and 
respiratory conditions that could possibly be reduced in severity with OSA treatment. While 
research continues, a three-step process has been identified to improve the screening, assessment, 
and referral process.   
The first step emphasizes the importance of the clinic nurse identifying patients at high-
risk for OSA in primary care settings. While obtaining the patient’s health history and changes in 
medications, nurses would ask about signs and symptoms (snoring, witnessed apneas, nocturnal 
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gasping or choking) and check the medical record for certain co-morbid conditions associated 
with OSA (BMI > 35, congestive heart failure, atrial fibrillation, hypertension, type II diabetes) 
(Miller & Berger, 2016). If the patients states that he/she has a sign or symptom or co-morbid 
condition(s) making them high-risk for OSA, the nurse would administer a screening measure 
with high levels of sensitivity, such as the STOP Bang (Chung et al., 2008a). The measure would 
then be scored and patients with a positive OSA screen (≥ 5) would be flagged. The ESS would 
be administered to measure daytime sleepiness levels. A trained health care provider could then 
conduct a clinical assessment. 
  The second step includes an assessment conducted by a health care provider. The 
assessment for OSA includes an examination of cardiovascular and respiratory systems including 
visual inspection of the oral-naso-pharynx (Epstein et al., 2009). If the provider suspects the 
presence of OSA, the patient would be evaluated for possible use of PSM.  
The third step involves OSA evaluation with PSM. Patients who are appropriate for PSM 
are outlined in the AASM Clinical Guidelines (Collop et al., 2007). If the patient is suspected of 
having OSA and had a co-morbid condition that excluded him/her from PSM, a referral to a sleep 
specialist must be provided. In patients who receive PSM in primary care or specialty settings, 
results from PSM may be automatically scored by the primary care provider or specialty 
clinician. If the results of the PSM indicate AHI levels ≥ 15, the patient should be referred a sleep 
specialist for further evaluation. From this point, the sleep specialist can interpret the PSM data 
and decide whether treatment can be prescribed from the study or if laboratory PSG testing is 
warranted. If AHI levels were < 15 and the patient is not experiencing daytime sleepiness 
symptoms, the clinician should encourage weight and blood pressure management. These patients 
should be flagged for re-evaluation for OSA in 6 months. 
AASM suggests that treatment modalities for OSA should not be prescribed by primary 
care or specialty providers because a comprehensive sleep evaluation is needed. Only sleep 
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specialists should prescribe OSA treatment methodologies from AHI levels from PSM as they 
have been trained to analyze the data manually (Collop et al., 2007).   
In conclusion, further testing of the STOP Bang is necessary in primary care and 
specialty settings. There is not one OSA screening measure that can be widely implemented 
across clinical settings without clinical assessment, but the STOP Bang has shown to have the 
highest levels of sensitivity. More education is needed in primary care and specialty clinics. PSM 
can aide in the referral process to sleep specialists but are not without flaws, such as equipment 
failure and misplacement of sensors. More PSM research is needed to further establish reliability 
and validity testing in outpatient settings. This three-step process for screening, diagnosis, and 
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Berlin Questionnaire  
Scoring Berlin questionnaire 
Adapted from: from Netzer, et al., 1999. (Netzer NC, Stoohs RA, Netzer CM, Clark K, 
Strohl KP.Using the Berlin Questionnaire to identify patients at risk for the sleep apnea 
syndrome. Ann Intern Med. 1999 Oct 5;131(7):485-91). 
The questionnaire consists of 3 categories related to the risk of having sleep apnea. 
 
Patients can be classified into High-Risk or Low Risk based on their responses to the 
individual items and their overall scores in the symptom categories. 
 
Categories and scoring: Category 
1: items 1, 2, 3, 4, 5. Item 1: if 
‘Yes’, assign 1 point 
Item 2: if ‘c’ or ‘d’ is the response, assign 1 point Item 
3: if ‘a’ or ‘b’ is the response, assign 1 point Item 4: 
if ‘a’ is the response, assign 1 point 
Item 5: if ‘a’ or ‘b’ is the response, assign 2 points 
 
Add points. Category 1 is positive if the total score is 2 or more points 
Category 2: items 6, 7, 8 (item 9 should be noted separately). Item 6: if 
‘a’ or ‘b’ is the response, assign 1 point 
Item 7: if ‘a’ or ‘b’ is the response, assign 1 point 
Item 8: if ‘a’ is the response, assign 1 point 
 
Add points. Category 2 is positive if the total score is 2 or more points Category 3 is 
positive if the answer to item 10 is ‘Yes’ OR if the BMI of the patient is greater 
than 30kg/m2. 
(BMI must be calculated. BMI is defined as weight (kg) divided by height (m) squared, i.e., 
kg/m2). 
High-Risk: if there are 2 or more Categories where the score is positive 
Low Risk: if there is only 1 or no Categories where the score is positive 
Additional question: item 9 should be noted separately. 
 
Berlin Questionnaire 
Height (m) Weight (kg) Age Male / 





1. Do you snore? 
_ a. Yes 
_ b. No 
_ c. Don’t know 
 
If you snore: 
2. Your snoring is: 
_ a. Slightly louder than breathing 
_ b. As loud as talking 
_ c. Louder than talking 
_ d. Very loud – can be heard in adjacent 
rooms 
 
3. How often do you snore 
_ a. Nearly every day 
_ b. 3-4 times a week 
_ c. 1-2 times a week 
_ d. 1-2 times a month 
_ e. Never or nearly never 
 
4. Has your snoring ever bothered 
other people? 
_ a. Yes 
_ b. No 
_ c. Don’t Know 
5. Has anyone noticed that you quit 
breathing during your sleep? 
 
_ a. Nearly every day 
_ b. 3-4 times a week 
_ c. 1-2 times a week 
_ d. 1-2 times a month 
_ e. Never or nearly never 
CATEGORY 2 
6. How often do you feel tired or 
fatigued after your sleep? 
_ a. Nearly every day 
_ b. 3-4 times a week 
_ c. 1-2 times a week 
_ d. 1-2 times a month 
_ e. Never or nearly never 
 
7. During your waking time, do you 
feel tired, fatigued or not up to par? 
_ a. Nearly every day 
_ b. 3-4 times a week 
_ c. 1-2 times a week 
_ d. 1-2 times a month 
_ e. Never or nearly never 
 
8. Have you ever nodded off or fallen 
asleep while driving a vehicle? 
_ a. Yes 
_ b. No 
 
If yes: 
9. How often does this occur? 
_ a. Nearly every day 
_ b. 3-4 times a week 
_ c. 1-2 times a week 
_ d. 1-2 times a month 
_ e. Never or nearly never 
 
CATEGORY 3 
10. Do you have high blood pressure? 
_ Yes 
_ No 






The Epworth Sleepiness Scale 
The Epworth Sleepiness Scale is widely used in the field of sleep medicine as a subjective measure of 
a patient's sleepiness.  The test is a list of eight situations in which you rate your tendency to become  
sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing.  When you finish the test, add 
up the values of your responses. Your total score is based on a scale of 0 to 24. The scale estimates 
whether you are experiencing excessive sleepiness that possibly requires medical    attention. 
How Sleepy Are You? 
How likely are you to doze off or fall asleep in the following situations? You should rate your 
chances of dozing off, not just feeling tired. Even if you have not done some of these things recently 
try to determine how they would have affected you. For each situation, decide whether or not you 
would have: 
 
 No chance of dozing =0 
 Slight chance of dozing =1 
 Moderate chance of dozing =2 
 High chance of dozing =3 
Write down the number corresponding to your choice in the right hand column. Total your score below. 
 
Situation Chance of Dozing 
Sitting and reading  
Watching TV  
Sitting inactive in a public place (e.g., a theater or a 
meeting) 
 
As a passenger in a car for an hour without a 
break 
 
Lying down to rest in the afternoon when 
circumstances permit 
 
Sitting and talking to someone  
Sitting quietly after a lunch without  alcohol  
In a car, while stopped for a few minutes in traffic  
 
Total Score = 
 
Analyze Your Score 
0-7:It is unlikely that you are abnormally sleepy. 
8-9:You have an average amount of daytime sleepiness. 
10-15:You may be excessively sleepy depending on the situation. You may want 
to consider seeking medical attention. 
16-24:You are excessively sleepy and should consider seeking medical attention. 
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Yes 





Do you Snore Loudly (loud enough to be heard through closed doors or your bed-partner  








Do you often feel Tired, Fatigued, or Sleepy during the daytime (such as falling asleep 




































Neck size large? (Measured around Adams apple)  
For male, is your shirt collar 17 inches/43 cm or larger?   







  Gender = Male? 
 
 
